c-Myc	B-protein
and	O
E1A	B-protein
induced	O
cellular	O
sensitivity	O
to	O
activated	B-cell_type
NK	I-cell_type
cells	I-cell_type
involves	O
cytotoxic	O
granules	O
as	O
death	O
effectors	O
.	O

The	O
contact	O
of	O
natural	B-cell_type
killer	I-cell_type
(	I-cell_type
NK	I-cell_type
)	I-cell_type
cells	I-cell_type
with	O
foreign	B-cell_type
cells	I-cell_type
and	O
with	O
certain	O
virus-infected	B-cell_type
or	I-cell_type
tumor	I-cell_type
cells	I-cell_type
triggers	O
the	O
cytolytic	O
machinery	O
of	O
NK	B-cell_type
cells	I-cell_type
.	O

This	O
triggering	O
leads	O
to	O
exocytosis	O
of	O
the	O
cytotoxic	B-cell_type
NK	I-cell_type
cell	I-cell_type
granules	I-cell_type
.	O

The	O
oncoproteins	B-protein
c-Myc	B-protein
and	O
E1A	B-protein
render	O
cells	O
vulnerable	O
to	O
NK	O
cell	O
mediated	O
cytolysis	O
yet	O
the	O
mechanisms	O
of	O
sensitization	O
are	O
not	O
well	O
understood	O
.	O

In	O
a	O
model	O
where	O
foreign	B-cell_type
cells	I-cell_type
(	O
rat	B-cell_type
fibroblasts	I-cell_type
)	O
were	O
cocultured	O
with	O
human	B-cell_type
IL-2	I-cell_type
activated	I-cell_type
NK	I-cell_type
cells	I-cell_type
,	O
we	O
observed	O
that	O
NK	B-cell_type
cells	I-cell_type
were	O
capable	O
of	O
efficiently	O
killing	O
their	O
targets	O
only	O
if	O
the	O
cells	O
overexpressed	O
the	O
oncogene	O
c-Myc	B-protein
or	O
E1A	B-protein
.	O

Both	O
the	O
parental	O
and	O
the	O
oncogene	B-cell_type
expressing	I-cell_type
fibroblasts	I-cell_type
similarly	O
triggered	O
phosphoinositide	O
hydrolysis	O
in	O
the	O
bound	O
NK	B-cell_type
cells	I-cell_type
,	O
demonstrating	O
that	O
NK	B-cell_type
cells	I-cell_type
were	O
cytolytically	O
activated	O
in	O
contact	O
with	O
both	O
resistant	O
parental	O
and	O
oncogene	B-cell_type
expressing	I-cell_type
sensitive	I-cell_type
target	I-cell_type
fibroblasts	I-cell_type
.	O

The	O
cell	O
death	O
was	O
independent	O
of	O
wild-type	B-protein
p53	I-protein
and	O
was	O
not	O
inhibited	O
by	O
an	O
anti-apoptotic	B-protein
protein	I-protein
EIB19K	I-protein
.	O

These	O
results	O
provided	O
evidence	O
that	O
c-Myc	B-protein
and	O
E1A	B-protein
activated	O
the	O
NK	O
cell	O
induced	O
cytolysis	O
at	O
a	O
post-triggering	O
stage	O
of	O
NK	O
cell-target	O
cell	O
interaction	O
.	O

In	O
consistence	O
,	O
the	O
c-Myc	B-protein
and	O
E1A	B-protein
overexpressing	O
fibroblasts	B-cell_type
were	O
more	O
sensitive	O
to	O
the	O
cytolytic	O
effects	O
of	O
isolated	O
NK	O
cell-derived	O
granules	O
than	O
parental	B-cell_type
cells	I-cell_type
.	O

The	O
data	O
indicate	O
that	O
oncogenes	B-DNA
activate	O
the	O
cytotoxicity	O
of	O
NK	O
cell	O
granules	O
.	O

This	O
mechanism	O
can	O
have	O
a	O
role	O
in	O
directing	O
the	O
cytolytic	O
action	O
of	O
NK	B-cell_type
cells	I-cell_type
towards	O
the	O
virus-infected	B-cell_type
and	I-cell_type
cancer	I-cell_type
cells	I-cell_type
.	O

Oncogene	NULL
(	NULL
1999	NULL
)	NULL
18	NULL
,	NULL
2181-2188	NULL
©	NULL
1999	NULL
Stockton	NULL
Press	NULL
All	NULL
rights	NULL
reserved	NULL
0950-9232/99	NULL
$	NULL
12.00	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

stockton-press.co.uk/onc	NULL
c-Myc	NULL
and	NULL
E1A	NULL
induced	NULL
cellular	NULL
sensitivity	NULL
to	NULL
activated	NULL
NK	NULL
cells	NULL
involves	NULL
cytotoxic	NULL
granules	NULL
as	NULL
death	NULL
effectors	NULL
Juha	NULL
Klefstrom*	NULL
``	NULL
,	NULL
Panu	NULL
E	NULL
Kovanen	NULL
'	NULL
,	NULL
Kristina	NULL
Somersalo®	NULL
,	NULL
Anne-Odile	NULL
Hueber	NULL
'	NULL
,	NULL
Trevor	NULL
Littlewood	NULL
'	NULL
,	NULL
Gerard	NULL
I	NULL
Evan	NULL
'	NULL
,	NULL
Arnold	NULL
H	NULL
Greenberg	NULL
``	NULL
,	NULL
Eero	NULL
Saksela®	NULL
,	NULL
Tuomo	NULL
Timonen	NULL
and	NULL
Kari	NULL
Alitalo®	NULL
'Biochemistry	NULL
of	NULL
the	NULL
Cell	NULL
Nucleus	NULL
Laboratory	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
123	NULL
,	NULL
44	NULL
Lincoln	NULL
's	NULL
Inn	NULL
Fields	NULL
,	NULL
London	NULL
WC2A	NULL
3PX	NULL
,	NULL
UK	NULL
;	NULL
``	NULL
Molecular	NULL
{	NULL
Cancer	NULL
Biology	NULL
Laboratory	NULL
and	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
Haartman	NULL
Institute	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
21	NULL
,	NULL
00014	NULL
University	NULL
of	NULL
Helsinki	NULL
,	NULL
Finland	NULL
;	NULL
Manitoba	NULL
Institute	NULL
of	NULL
Cell	NULL
Biology	NULL
,	NULL
Departments	NULL
of	NULL
Pediatrics	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Manitoba	NULL
,	NULL
Winnipeg	NULL
,	NULL
Manitoba	NULL
R3E	NULL
0V9	NULL
,	NULL
Canada	NULL
The	NULL
contact	NULL
of	NULL
natural	NULL
killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
with	NULL
foreign	NULL
cells	NULL
and	NULL
with	NULL
certain	NULL
virus-infected	NULL
or	NULL
tumor	NULL
cells	NULL
triggers	NULL
the	NULL
cytolytic	NULL
machinery	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

This	NULL
triggering	NULL
leads	NULL
to	NULL
exocytosis	NULL
of	NULL
the	NULL
cytotoxic	NULL
NK	NULL
cell	NULL
granules	NULL
.	NULL

The	NULL
oncoproteins	NULL
c-Myc	NULL
and	NULL
E1A	NULL
render	NULL
cells	NULL
vulnerable	NULL
to	NULL
NK	NULL
cell	NULL
mediated	NULL
cytolysis	NULL
yet	NULL
the	NULL
mechanisms	NULL
of	NULL
sensitization	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

In	NULL
a	NULL
model	NULL
where	NULL
foreign	NULL
cells	NULL
(	NULL
rat	NULL
fibroblasts	NULL
)	NULL
were	NULL
cocultured	NULL
with	NULL
human	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
NK	NULL
cells	NULL
were	NULL
capable	NULL
of	NULL
efficiently	NULL
killing	NULL
their	NULL
targets	NULL
only	NULL
if	NULL
the	NULL
cells	NULL
overexpressed	NULL
the	NULL
oncogene	NULL
c-Myc	NULL
or	NULL
EIA	NULL
.	NULL

Both	NULL
the	NULL
parental	NULL
and	NULL
the	NULL
oncogene	NULL
expressing	NULL
fibroblasts	NULL
similarly	NULL
triggered	NULL
phosphoinositide	NULL
hydrolysis	NULL
in	NULL
the	NULL
bound	NULL
NK	NULL
cells	NULL
,	NULL
demonstrating	NULL
that	NULL
NK	NULL
cells	NULL
were	NULL
cytolytically	NULL
activated	NULL
in	NULL
contact	NULL
with	NULL
both	NULL
resistant	NULL
parental	NULL
and	NULL
oncogene	NULL
expressing	NULL
sensitive	NULL
target	NULL
fibroblasts	NULL
.	NULL

The	NULL
cell	NULL
death	NULL
was	NULL
independent	NULL
of	NULL
wild-type	NULL
pS3	NULL
and	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
an	NULL
anti-apoptotic	NULL
protein	NULL
E1B19K	NULL
.	NULL

These	NULL
results	NULL
provided	NULL
evidence	NULL
that	NULL
c-Myc	NULL
and	NULL
E1A	NULL
activated	NULL
the	NULL
NK	NULL
cell	NULL
induced	NULL
cytolysis	NULL
at	NULL
a	NULL
post-triggering	NULL
stage	NULL
of	NULL
NK	NULL
cell-target	NULL
cell	NULL
interaction	NULL
.	NULL

In	NULL
consistence	NULL
,	NULL
the	NULL
c-Mye	NULL
and	NULL
E1A	NULL
overexpressing	NULL
fibroblasts	NULL
were	NULL
more	NULL
sensitive	NULL
to	NULL
the	NULL
cytolytic	NULL
effects	NULL
of	NULL
isolated	NULL
NK	NULL
cell-derived	NULL
granules	NULL
than	NULL
parental	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
indicate	NULL
that	NULL
oncogenes	NULL
activate	NULL
the	NULL
cytotoxicity	NULL
of	NULL
NK	NULL
cell	NULL
granules	NULL
.	NULL

This	NULL
mechanism	NULL
can	NULL
have	NULL
a	NULL
role	NULL
in	NULL
directing	NULL
the	NULL
cytolytic	NULL
action	NULL
of	NULL
NK	NULL
cells	NULL
towards	NULL
the	NULL
virus-infected	NULL
and	NULL
cancer	NULL
cells	NULL
.	NULL

Keywords	NULL
:	NULL
apoptosis	NULL
;	NULL
c-Myc	NULL
;	NULL
ElA	NULL
;	NULL
NK	NULL
cells	NULL
;	NULL
cytotoxicity	NULL
Introduction	NULL
Natural	NULL
Killer	NULL
(	NULL
NK	NULL
)	NULL
cells	NULL
are	NULL
cytotoxic	NULL
lymphocytes	NULL
that	NULL
express	NULL
a	NULL
pattern	NULL
of	NULL
antigens	NULL
different	NULL
from	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
and	NULL
do	NULL
not	NULL
rearrange	NULL
their	NULL
T	NULL
cell	NULL
receptor	NULL
or	NULL
immunoglobulin	NULL
genes	NULL
.	NULL

NK	NULL
cells	NULL
are	NULL
spontaneously	NULL
cytotoxic	NULL
to	NULL
many	NULL
virus-infected	NULL
cells	NULL
and	NULL
tumor	NULL
cell	NULL
targets	NULL
,	NULL
but	NULL
the	NULL
molecular	NULL
mechanisms	NULL
which	NULL
direct	NULL
the	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
towards	NULL
these	NULL
cells	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

*Correspondence	NULL
:	NULL
J	NULL
Klefstrom	NULL
JK	NULL
and	NULL
PEK	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
Received	NULL
17	NULL
June	NULL
1998	NULL
;	NULL
revised	NULL
28	NULL
October	NULL
1998	NULL
;	NULL
accepted	NULL
29	NULL
October	NULL
1998	NULL
NK	NULL
cells	NULL
are	NULL
able	NULL
to	NULL
conjugate	NULL
transiently	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
cells	NULL
.	NULL

This	NULL
initial	NULL
binding	NULL
phase	NULL
together	NULL
with	NULL
positive	NULL
and	NULL
negative	NULL
signals	NULL
that	NULL
the	NULL
NK	NULL
cells	NULL
receive	NULL
from	NULL
target	NULL
cells	NULL
determine	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NK	NULL
cell	NULL
cytolytic	NULL
machinery	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
the	NULL
recognition	NULL
of	NULL
foreign	NULL
peptides	NULL
bound	NULL
to	NULL
major	NULL
histocompatibility	NULL
complex	NULL
(	NULL
MHC	NULL
)	NULL
class	NULL
I	NULL
molecules	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
NK	NULL
cell	NULL
cytolytic	NULL
activity	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
inhibitory	NULL
NK	NULL
cell	NULL
receptor	NULL
molecules	NULL
that	NULL
recognize	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
on	NULL
target	NULL
cells	NULL
(	NULL
Lanier	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
MHC-based	NULL
control	NULL
of	NULL
NK	NULL
cell	NULL
activity	NULL
is	NULL
thought	NULL
to	NULL
protect	NULL
normal	NULL
cells	NULL
In	NULL
contrast	NULL
,	NULL
transformed	NULL
or	NULL
virally	NULL
infected	NULL
cells	NULL
which	NULL
downregulate	NULL
MHC	NULL
expression	NULL
,	NULL
are	NULL
sensitive	NULL
to	NULL
cytolysis	NULL
(	NULL
Brutkiewicz	NULL
and	NULL
Welsh	NULL
,	NULL
1995	NULL
;	NULL
Ljunggren	NULL
and	NULL
Kirre	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Receptors	NULL
that	NULL
trigger	NULL
NK	NULL
cell	NULL
activity	NULL
are	NULL
less	NULL
well	NULL
characterized	NULL
,	NULL
but	NULL
include	NULL
at	NULL
least	NULL
Fce-receptor-type	NULL
III	NULL
or	NULL
CD16	NULL
,	NULL
C-type	NULL
lectin	NULL
receptors	NULL
,	NULL
killer	NULL
cell	NULL
activating	NULL
receptors	NULL
(	NULL
KARs	NULL
)	NULL
and	NULL
B2	NULL
?	NULL

-integrins	NULL
(	NULL
Helander	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Raulet	NULL
and	NULL
Held	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Triggering	NULL
of	NULL
NK	NULL
cell	NULL
cytolytic	NULL
machinery	NULL
results	NULL
in	NULL
the	NULL
directed	NULL
exocytosis	NULL
of	NULL
cytotoxic	NULL
granules	NULL
(	NULL
Berke	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

These	NULL
granules	NULL
are	NULL
the	NULL
primary	NULL
mediators	NULL
of	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
,	NULL
and	NULL
the	NULL
major	NULL
granule	NULL
components	NULL
involved	NULL
in	NULL
the	NULL
cytotoxic	NULL
process	NULL
are	NULL
a	NULL
membrane	NULL
pore-forming	NULL
protein	NULL
called	NULL
perforin	NULL
and	NULL
serine	NULL
proteases	NULL
called	NULL
granzymes	NULL
.	NULL

Perforin	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
apoptosis	NULL
by	NULL
granzyme	NULL
B	NULL
and	NULL
the	NULL
translocation	NULL
of	NULL
granzyme	NULL
B	NULL
to	NULL
the	NULL
target	NULL
cell	NULL
nucleus	NULL
(	NULL
Jans	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
can	NULL
induce	NULL
target	NULL
cell	NULL
death	NULL
also	NULL
by	NULL
ligand	NULL
mediated	NULL
activation	NULL
of	NULL
CD95	NULL
on	NULL
target	NULL
cells	NULL
(	NULL
Arase	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Part	NULL
of	NULL
the	NULL
NK	NULL
cell	NULL
killing	NULL
activity	NULL
against	NULL
tumor	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
the	NULL
membrane	NULL
bound	NULL
or	NULL
soluble	NULL
forms	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF	NULL
)	NULL
(	NULL
Wright	NULL
and	NULL
Bonavida	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

The	NULL
oncogenic	NULL
expression	NULL
of	NULL
c-Myc	NULL
(	NULL
Versteeg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
or	NULL
adenoviral	NULL
E1A	NULL
(	NULL
Walker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
increases	NULL
the	NULL
susceptibility	NULL
of	NULL
target	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

This	NULL
effect	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
several	NULL
mechanisms	NULL
.	NULL

In	NULL
melanoma	NULL
cell	NULL
lines	NULL
c-Myc	NULL
overexpression	NULL
downregu-lates	NULL
MHC	NULL
class	NULL
I	NULL
expression	NULL
and	NULL
sensitizes	NULL
the	NULL
cells	NULL
to	NULL
NK	NULL
cytolysis	NULL
(	NULL
Peltenburg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Versteeg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
sensitization	NULL
can	NULL
be	NULL
reversed	NULL
by	NULL
reintroduc-tion	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
by	NULL
transfection	NULL
.	NULL

In	NULL
other	NULL
types	NULL
of	NULL
cells	NULL
,	NULL
c-Myc	NULL
increases	NULL
the	NULL
sensitivity	NULL
of	NULL
target	NULL
cells	NULL
to	NULL
NK	NULL
cell-induced	NULL
lysis	NULL
without	NULL
altering	NULL
MHC	NULL
class	NULL
I	NULL
expression	NULL
,	NULL
possibly	NULL
by	NULL
increasing	NULL
the	NULL
adhesive-ness	NULL
of	NULL
NK	NULL
cells	NULL
to	NULL
the	NULL
targets	NULL
(	NULL
Cuomo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
La	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
2182	NULL
Cava	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
oncogenes	NULL
can	NULL
have	NULL
effects	NULL
on	NULL
the	NULL
target	NULL
cell	NULL
surface	NULL
which	NULL
facilitate	NULL
the	NULL
triggering	NULL
of	NULL
the	NULL
cytolytic	NULL
machinery	NULL
of	NULL
NK	NULL
cells	NULL
during	NULL
NK	NULL
cell-target	NULL
cell	NULL
interaction	NULL
.	NULL

c-Myc	NULL
or	NULL
EIA	NULL
could	NULL
also	NULL
induce	NULL
target	NULL
cell	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
by	NULL
increasing	NULL
their	NULL
sensitivity	NULL
to	NULL
TNF-mediated	NULL
killing	NULL
mechanisms	NULL
(	NULL
Chen	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Klefstrom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
certain	NULL
instances	NULL
,	NULL
antibodies	NULL
blocking	NULL
TNF	NULL
inhibit	NULL
the	NULL
ElA-induced	NULL
sensitivity	NULL
of	NULL
mouse	NULL
fibroblasts	NULL
to	NULL
mouse	NULL
NK	NULL
cell	NULL
cytotoxicity	NULL
(	NULL
Cook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Recent	NULL
data	NULL
indicate	NULL
that	NULL
c-Myc	NULL
and	NULL
ElA	NULL
can	NULL
also	NULL
induce	NULL
the	NULL
cellular	NULL
sensitivity	NULL
to	NULL
CD95	NULL
ligand	NULL
(	NULL
CD9SL	NULL
)	NULL
-induced	NULL
death	NULL
(	NULL
Cook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Hueber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
present	NULL
evidence	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
so	NULL
far	NULL
described	NULL
mechanisms	NULL
of	NULL
sensitization	NULL
,	NULL
oncogenes	NULL
also	NULL
have	NULL
a	NULL
role	NULL
at	NULL
a	NULL
post-triggering	NULL
stage	NULL
of	NULL
the	NULL
cytolytic	NULL
action	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
present	NULL
results	NULL
show	NULL
that	NULL
the	NULL
oncogenes	NULL
c-Myc	NULL
and	NULL
EIA	NULL
sensitize	NULL
cells	NULL
to	NULL
apoptosis	NULL
by	NULL
NK	NULL
cell	NULL
derived	NULL
cytotoxic	NULL
granules	NULL
and	NULL
the	NULL
dependence	NULL
of	NULL
granule	NULL
mediated	NULL
cell	NULL
death	NULL
on	NULL
this	NULL
sensitization	NULL
.	NULL

Results	NULL
c-Myc	NULL
and	NULL
ElA	NULL
induce	NULL
susceptibility	NULL
of	NULL
Rat1	NULL
fibroblasts	NULL
to	NULL
cytolysis	NULL
by	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
We	NULL
studied	NULL
if	NULL
oncoproteins	NULL
can	NULL
modulate	NULL
target	NULL
cell	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
killing	NULL
in	NULL
a	NULL
model	NULL
where	NULL
NK	NULL
cells	NULL
were	NULL
expected	NULL
to	NULL
recognize	NULL
target	NULL
cells	NULL
as	NULL
foreign	NULL
cells	NULL
and	NULL
expose	NULL
them	NULL
to	NULL
cytolytic	NULL
attack	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
applied	NULL
a	NULL
xenogeneic	NULL
cell	NULL
model	NULL
in	NULL
which	NULL
Ratl	NULL
fibroblasts	NULL
were	NULL
used	NULL
as	NULL
targets	NULL
of	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

Ratl	NULL
cells	NULL
,	NULL
or	NULL
their	NULL
derivatives	NULL
constitutively	NULL
overexpressing	NULL
E1A	NULL
(	NULL
Rat1-E1A	NULL
)	NULL
or	NULL
c-Myc	NULL
(	NULL
Rat1-Myc	NULL
)	NULL
were	NULL
cocultured	NULL
either	NULL
with	NULL
human	NULL
NK	NULL
cells	NULL
or	NULL
with	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
activated	NULL
human	NULL
NK	NULL
cells	NULL
for	NULL
3	NULL
days	NULL
.	NULL

A	NULL
rapidly	NULL
progressing	NULL
cell	NULL
death	NULL
of	NULL
c-Myc	NULL
or	NULL
ElA	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
occurred	NULL
in	NULL
cultures	NULL
with	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
(	NULL
Figure	NULL
la	NULL
)	NULL
,	NULL
whereas	NULL
clearly	NULL
less	NULL
cell	NULL
death	NULL
occurred	NULL
in	NULL
cocultures	NULL
with	NULL
parental	NULL
Ratl	NULL
cells	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
oncogene	NULL
expressing	NULL
target	NULL
cells	NULL
died	NULL
during	NULL
24	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
whereas	NULL
parental	NULL
Ratl	NULL
cells	NULL
survived	NULL
over	NULL
the	NULL
3	NULL
day	NULL
assay	NULL
period	NULL
.	NULL

The	NULL
in	NULL
sity	NULL
DNA	NULL
nick	NULL
end-labeling	NULL
(	NULL
TUNEL	NULL
)	NULL
revealed	NULL
specific	NULL
staining	NULL
of	NULL
fibroblastic	NULL
cells	NULL
with	NULL
an	NULL
apoptotic	NULL
morphology	NULL
(	NULL
Figure	NULL
1b	NULL
)	NULL
.	NULL

Upon	NULL
quantitation	NULL
by	NULL
the	NULL
MTT	NULL
assay	NULL
it	NULL
was	NULL
found	NULL
that	NULL
the	NULL
Rat1-Mye	NULL
and	NULL
Rat1-El1A	NULL
cells	NULL
died	NULL
in	NULL
a	NULL
logarithmic	NULL
fashion	NULL
in	NULL
response	NULL
to	NULL
increasing	NULL
amounts	NULL
of	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
(	NULL
Figure	NULL
1¢c	NULL
)	NULL
.	NULL

The	NULL
4:1	NULL
effector	NULL
target	NULL
ratio	NULL
resulted	NULL
in	NULL
less	NULL
than	NULL
20	NULL
%	NULL
relative	NULL
survival	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Higher	NULL
ratios	NULL
of	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
to	NULL
Ratl1	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
decreased	NULL
cell	NULL
survival	NULL
,	NULL
yet	NULL
more	NULL
than	NULL
half	NULL
of	NULL
the	NULL
parental	NULL
Ratl	NULL
cells	NULL
survived	NULL
even	NULL
the	NULL
highest	NULL
NK	NULL
cell	NULL
ratios	NULL
analysed	NULL
(	NULL
16:1	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
death	NULL
is	NULL
independent	NULL
of	NULL
wild-type	NULL
p53	NULL
activity	NULL
and	NULL
is	NULL
not	NULL
inhibited	NULL
by	NULL
an	NULL
adenoviral	NULL
anti-apoptotic	NULL
protein	NULL
EIBIIK	NULL
The	NULL
apoptotic	NULL
functions	NULL
of	NULL
c-Myc	NULL
(	NULL
Wagner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
EIA	NULL
(	NULL
Debbas	NULL
and	NULL
White	NULL
,	NULL
1993	NULL
)	NULL
are	NULL
often	NULL
manifested	NULL
only	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
wild-type	NULL
p53	NULL
.	NULL

Ratl	NULL
cells	NULL
express	NULL
wild-type	NULL
p53	NULL
and	NULL
its	NULL
role	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
c-Myc	NULL
or	NULL
ElA	NULL
induced	NULL
cellular	NULL
susceptibility	NULL
to	NULL
NK	NULL
cell	NULL
cytolysis	NULL
was	NULL
studied	NULL
.	NULL

The	NULL
carboxyterminal	NULL
transforming	NULL
domain	NULL
of	NULL
p53	NULL
,	NULL
(	NULL
pS53Cter	NULL
,	NULL
p53	NULL
residues	NULL
302-390	NULL
,	NULL
see	NULL
Shaulian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
was	NULL
introduced	NULL
into	NULL
Ratl	NULL
,	NULL
Ratl-ElA	NULL
and	NULL
Ratl-Mye	NULL
cells	NULL
.	NULL

p53Cter	NULL
forms	NULL
stable	NULL
heteromeric	NULL
complexes	NULL
with	NULL
the	NULL
wild-type	NULL
p53	NULL
.	NULL

This	NULL
inhibits	NULL
the	NULL
wild-type	NULL
p53	NULL
activity	NULL
since	NULL
heteromeric	NULL
complexes	NULL
can	NULL
not	NULL
activate	NULL
transcription	NULL
(	NULL
Shaulian	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
,	NULL
1995	NULL
;	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
dominant-negative	NULL
role	NULL
of	NULL
p53Cter	NULL
in	NULL
Ratl	NULL
cells	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
pS53Cter	NULL
reduces	NULL
the	NULL
rate	NULL
of	NULL
p53-dependent	NULL
,	NULL
X-irradiation	NULL
induced	NULL
apoptosis	NULL
to	NULL
one	NULL
fifth	NULL
of	NULL
that	NULL
of	NULL
the	NULL
control	NULL
cells	NULL
(	NULL
Klefstrom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
killed	NULL
Ratl-Mye	NULL
and	NULL
Ratl-E1A	NULL
cells	NULL
expressing	NULL
p53Cter	NULL
with	NULL
a	NULL
similar	NULL
efficiency	NULL
as	NULL
they	NULL
killed	NULL
parental	NULL
oncoprotein	NULL
expressing	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
the	NULL
4:1	NULL
ratio	NULL
of	NULL
effector	NULL
cells	NULL
to	NULL
target	NULL
cells	NULL
resulted	NULL
in	NULL
less	NULL
than	NULL
20	NULL
%	NULL
relative	NULL
survival	NULL
of	NULL
the	NULL
target	NULL
cells	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
if	NULL
EIBI9K	NULL
,	NULL
an	NULL
adenovirus-encoded	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
,	NULL
modulated	NULL
the	NULL
E1A-induced	NULL
NK	NULL
cell	NULL
sensitivity	NULL
of	NULL
Ratl	NULL
cells	NULL
.	NULL

The	NULL
Ratl	NULL
cells	NULL
expressing	NULL
both	NULL
EIA	NULL
and	NULL
El1BI9K	NULL
were	NULL
killed	NULL
as	NULL
efficiently	NULL
as	NULL
Ratl	NULL
cells	NULL
expressing	NULL
ElA	NULL
alone	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
NK	NULL
cytotoxicity-resistant	NULL
Ratl	NULL
cells	NULL
and	NULL
the	NULL
oncoprotein	NULL
expressing	NULL
cytotoxicity-sensitive	NULL
Ratl	NULL
cells	NULL
bind	NULL
NK	NULL
cells	NULL
and	NULL
induce	NULL
F-actin	NULL
polarization	NULL
and	NULL
phosphoinositide	NULL
hydrolysis	NULL
in	NULL
the	NULL
bound	NULL
NK	NULL
cells	NULL
The	NULL
adhesion	NULL
assays	NULL
showed	NULL
that	NULL
NK	NULL
cells	NULL
bound	NULL
to	NULL
their	NULL
targets	NULL
and	NULL
that	NULL
the	NULL
binding	NULL
was	NULL
similar	NULL
to	NULL
Ratl	NULL
,	NULL
Ratl-EIA	NULL
and	NULL
Ratl-Myc	NULL
cells	NULL
(	NULL
Figure	NULL
3a	NULL
)	NULL
.	NULL

Further-more	NULL
,	NULL
IL-2	NULL
treatment	NULL
increased	NULL
the	NULL
binding	NULL
of	NULL
NK	NULL
cells	NULL
to	NULL
all	NULL
target	NULL
cells	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
.	NULL

The	NULL
fluorescence	NULL
microscopy	NULL
of	NULL
phalloidin-stained	NULL
,	NULL
target	NULL
bound	NULL
NK	NULL
cells	NULL
revealed	NULL
prominent	NULL
actin	NULL
polymerization	NULL
to	NULL
F-actin	NULL
form	NULL
at	NULL
the	NULL
cell-cell	NULL
contact	NULL
sites	NULL
(	NULL
Figure	NULL
3b	NULL
)	NULL
.	NULL

The	NULL
actin	NULL
polarization	NULL
,	NULL
which	NULL
indicates	NULL
the	NULL
cytolytic	NULL
activation	NULL
of	NULL
killer	NULL
cells	NULL
(	NULL
Berke	NULL
,	NULL
1994	NULL
;	NULL
Griffiths	NULL
,	NULL
1995	NULL
)	NULL
,	NULL
was	NULL
commonly	NULL
found	NULL
also	NULL
in	NULL
NK	NULL
cells	NULL
bound	NULL
to	NULL
Ratl	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
resistant	NULL
to	NULL
NK	NULL
cell-induced	NULL
death	NULL
(	NULL
Figure	NULL
3b	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
amount	NULL
of	NULL
cellular	NULL
inositolphosphates	NULL
whose	NULL
increased	NULL
generation	NULL
by	NULL
phosphoinositide	NULL
hydrolysis	NULL
occurs	NULL
during	NULL
the	NULL
exocytosis	NULL
of	NULL
the	NULL
cytotoxic	NULL
granules	NULL
(	NULL
Atkinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Chow	NULL
and	NULL
Jondal	NULL
,	NULL
1990	NULL
;	NULL
Stahls	NULL
and	NULL
Carpen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
NK	NULL
cells	NULL
with	NULL
the	NULL
parental	NULL
Ratl	NULL
cells	NULL
or	NULL
with	NULL
the	NULL
EIA	NULL
or	NULL
c-Myc	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
similar	NULL
increase	NULL
of	NULL
cellular	NULL
inositolmono-phosphate	NULL
(	NULL
inositol-P1	NULL
)	NULL
levels	NULL
(	NULL
Figure	NULL
3¢c	NULL
)	NULL
;	NULL
the	NULL
increase	NULL
was	NULL
4.7	NULL
,	NULL
4.1	NULL
and	NULL
3.6-fold	NULL
after	NULL
incubation	NULL
with	NULL
Ratl	NULL
,	NULL
Ratl-E1A	NULL
or	NULL
Rat1-Myc	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

c-Myc	NULL
and	NULL
ElA	NULL
enhance	NULL
cellular	NULL
susceptibility	NULL
to	NULL
the	NULL
lethal	NULL
effects	NULL
of	NULL
purified	NULL
cytotoxic	NULL
granules	NULL
The	NULL
accumulation	NULL
of	NULL
inositolphosphates	NULL
and	NULL
the	NULL
frequently	NULL
observed	NULL
F-actin	NULL
polarization	NULL
in	NULL
NK	NULL
cells	NULL
indicated	NULL
that	NULL
all	NULL
target	NULL
cells	NULL
activated	NULL
the	NULL
NK	NULL
cell	NULL
cytolytic	NULL
machinery	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
if	NULL
c-Myc	NULL
or	NULL
ElA	NULL
sensitized	NULL
Ratl	NULL
cells	NULL
to	NULL
the	NULL
lethal	NULL
effects	NULL
of	NULL
purified	NULL
cytotoxic	NULL
granules	NULL
.	NULL

The	NULL
control	NULL
Ratl	NULL
cells	NULL
containing	NULL
mock-vector	NULL
(	NULL
Ratl-pMV7	NULL
)	NULL
and	NULL
the	NULL
EIA	NULL
or	NULL
c-Myc	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
were	NULL
A	NULL
Photomicrographs	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
B	NULL
Tunel-staining	NULL
light-field	NULL
phase-contrast	NULL
Quantitation	NULL
of	NULL
cell	NULL
viability	NULL
0.5	NULL
10	NULL
20	NULL
4.0	NULL
8.0	NULL
16	NULL
effector	NULL
cell	NULL
:	NULL
target	NULL
cell	NULL
Figure	NULL
1	NULL
-	NULL
Selective	NULL
killing	NULL
of	NULL
ELA	NULL
or	NULL
c-Myc	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
by	NULL
IL-2	NULL
activated	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

Ratl	NULL
cells	NULL
,	NULL
or	NULL
Ratl	NULL
cell	NULL
clones	NULL
constitutively	NULL
overexpressing	NULL
ElA	NULL
(	NULL
Ratl-ElA	NULL
)	NULL
or	NULL
c-Myc	NULL
(	NULL
Ratl-Myc	NULL
)	NULL
were	NULL
cocultured	NULL
with	NULL
non-activated	NULL
or	NULL
with	NULL
IL-2	NULL
activated	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

For	NULL
activation	NULL
,	NULL
NK	NULL
cells	NULL
were	NULL
cultured	NULL
overnight	NULL
with	NULL
IL-2	NULL
(	NULL
500	NULL
U/ml	NULL
)	NULL
.	NULL

In	NULL
(	NULL
a	NULL
)	NULL
the	NULL
NK	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
target	NULL
cells	NULL
in	NULL
a	NULL
4:1	NULL
ratio	NULL
and	NULL
photomicrographs	NULL
of	NULL
the	NULL
cultures	NULL
were	NULL
taken	NULL
after	NULL
24	NULL
h	NULL
incubation	NULL
.	NULL

NK	NULL
cells	NULL
can	NULL
be	NULL
distinguished	NULL
by	NULL
their	NULL
small	NULL
size	NULL
,	NULL
giving	NULL
bright	NULL
spot-like	NULL
images	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
shows	NULL
target	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
middle	NULL
panel	NULL
target	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
NK	NULL
cells	NULL
and	NULL
in	NULL
the	NULL
right	NULL
panel	NULL
with	NULL
IL-2	NULL
treated	NULL
NK	NULL
cells	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Individual	NULL
Rat1-E1A	NULL
cells	NULL
show	NULL
positive	NULL
staining	NULL
in	NULL
TUNEL-assay	NULL
after	NULL
the	NULL
cells	NULL
were	NULL
cocultured	NULL
for	NULL
6	NULL
h	NULL
with	NULL
IL-2	NULL
stimulated	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
shows	NULL
a	NULL
light-field	NULL
and	NULL
right	NULL
panel	NULL
a	NULL
phase-contrast	NULL
micrograph	NULL
.	NULL

The	NULL
stained	NULL
cells	NULL
are	NULL
predominantly	NULL
fibroblasts	NULL
(	NULL
Inset	NULL
)	NULL
.	NULL

40	NULL
x	NULL
magnification	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Quantitation	NULL
of	NULL
cell	NULL
death	NULL
at	NULL
different	NULL
effector	NULL
cell-target	NULL
cell	NULL
ratios	NULL
.	NULL

The	NULL
survival	NULL
of	NULL
Ratl	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
,	NULL
Ratl-ElA	NULL
(	NULL
circles	NULL
)	NULL
and	NULL
Ratl-Myc	NULL
(	NULL
triangles	NULL
)	NULL
cells	NULL
cocultured	NULL
for	NULL
48	NULL
h	NULL
with	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
at	NULL
different	NULL
effector-target	NULL
cell	NULL
ratios	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
MTT-assay	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
+s.d	NULL
.	NULL

of	NULL
five	NULL
identical	NULL
experiments	NULL
100	NULL
€	NULL
$	NULL
No	NULL
NK	NULL
cells	NULL
D	NULL
NK	NULL
cells	NULL
B	NULL
NK	NULL
cells+IL-2	NULL
Cell	NULL
survival	NULL
(	NULL
%	NULL
)	NULL
B	NULL
bo	NULL
o	NULL
Figure	NULL
2	NULL
Expression	NULL
of	NULL
carboxyterminal	NULL
p53	NULL
domain	NULL
or	NULL
ElBI9K	NULL
in	NULL
the	NULL
oncoprotein-expressing	NULL
Ratl	NULL
cells	NULL
does	NULL
not	NULL
inhibit	NULL
the	NULL
NK	NULL
cell	NULL
induced	NULL
death	NULL
.	NULL

Ratl	NULL
,	NULL
Ratl-E1A	NULL
and	NULL
Ratl-Myc	NULL
cells	NULL
with	NULL
or	NULL
without	NULL
p53C	NULL
(	NULL
ter	NULL
)	NULL
were	NULL
cocultured	NULL
for	NULL
48	NULL
h	NULL
with	NULL
non-activated	NULL
or	NULL
with	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
at	NULL
a	NULL
4:1	NULL
effector	NULL
target	NULL
cell	NULL
ratio	NULL
prior	NULL
to	NULL
the	NULL
MTT-assay	NULL
.	NULL

Ratl	NULL
cells	NULL
simultaneously	NULL
expressing	NULL
ElA	NULL
and	NULL
E1B19K	NULL
were	NULL
also	NULL
assayed	NULL
in	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
six	NULL
independent	NULL
experiments	NULL
exposed	NULL
to	NULL
NK	NULL
cell-derived	NULL
RNK-granules	NULL
(	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
the	NULL
ensuing	NULL
cell	NULL
death	NULL
was	NULL
quantitated	NULL
.	NULL

When	NULL
the	NULL
integrity	NULL
of	NULL
cell	NULL
membranes	NULL
was	NULL
examined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
in	NULL
a	NULL
6	NULL
h	NULL
assay	NULL
,	NULL
Ratl-E1A	NULL
and	NULL
Ratl-Myc	NULL
cells	NULL
were	NULL
more	NULL
sensitive	NULL
than	NULL
Ratl-pMV7	NULL
cells	NULL
to	NULL
the	NULL
membrane	NULL
damaging	NULL
effects	NULL
of	NULL
RNK-granules	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
if	NULL
the	NULL
target	NULL
cell	NULL
lysis	NULL
by	NULL
Table	NULL
1	NULL
Cytolytic	NULL
effects	NULL
of	NULL
RNK-granules	NULL
Trypan	NULL
blue+	NULL
cells	NULL
(	NULL
%	NULL
)	NULL
EIA	NULL
Apoptotic	NULL
nuclei	NULL
(	NULL
%	NULL
)	NULL
EIA	NULL
Hours	NULL
-	NULL
c-Myc	NULL
-	NULL
Hours	NULL
-	NULL
c-Myc	NULL
2	NULL
0.5	NULL
0.4	NULL
1.4	NULL
0.9	NULL
0.4	NULL
0.4	NULL
20	NULL
1.1	NULL
2.3	NULL
1.6	NULL
4.3	NULL
0.3	NULL
3.3	NULL
4	NULL
3.7	NULL
1.4	NULL
1.3	NULL
3.9	NULL
1.1	NULL
6.7	NULL
3	NULL
1.7	NULL
3.7	NULL
2.1	NULL
14.7	NULL
0.8	NULL
10.9	NULL
6	NULL
1.7	NULL
6.7	NULL
1.6	NULL
34.0	NULL
0.7	NULL
18.8	NULL
4	NULL
1.4	NULL
3.3	NULL
1.7	NULL
18.5	NULL
1.7	NULL
24.0	NULL
o	NULL
o	NULL
aes	NULL
-o	NULL
t	NULL
-of	NULL
o	NULL
-o+	NULL
RNK-granules	NULL
RNK-granules	NULL
Mock	NULL
(	NULL
-	NULL
)	NULL
,	NULL
and	NULL
EIA	NULL
or	NULL
c-Myc	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
1:20	NULL
dilution	NULL
of	NULL
RNK-granules	NULL
for	NULL
indicated	NULL
time-periods	NULL
.	NULL

Left	NULL
panel	NULL
shows	NULL
the	NULL
percentage	NULL
of	NULL
trypan	NULL
blue	NULL
staining	NULL
cells	NULL
and	NULL
right	NULL
panel	NULL
of	NULL
apoptotic	NULL
nuclei	NULL
identified	NULL
by	NULL
propidium-iodide	NULL
staining	NULL
of	NULL
cells	NULL
.	NULL

Each	NULL
value	NULL
represents	NULL
the	NULL
mean	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
.	NULL

The	NULL
single	NULL
values	NULL
for	NULL
trypan	NULL
blue+cells	NULL
at	NULL
6	NULL
h	NULL
were	NULL
(	NULL
from	NULL
left	NULL
to	NULL
right	NULL
)	NULL
:	NULL
3.1/0.3	NULL
,	NULL
7.3/6.0	NULL
,	NULL
2.4/0.8	NULL
,	NULL
51/17	NULL
,	NULL
1.1/0.3	NULL
,	NULL
24.6/13.0	NULL
and	NULL
for	NULL
apoptotic	NULL
nuclei	NULL
at	NULL
4	NULL
h	NULL
:	NULL
0.0/2.8	NULL
,	NULL
1.5/5	NULL
,	NULL
0.7/2.6	NULL
,	NULL
20/16.9	NULL
,	NULL
2/1.4	NULL
,	NULL
18.6/29.4	NULL
granules	NULL
involved	NULL
apoptotic	NULL
nuclear	NULL
damage	NULL
the	NULL
treated	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
apoptosis	NULL
was	NULL
higher	NULL
in	NULL
the	NULL
cultures	NULL
of	NULL
oncoprotein-expressing	NULL
Ratl	NULL
cells	NULL
than	NULL
of	NULL
Ratl-pMV7	NULL
cells	NULL
;	NULL
at	NULL
4	NULL
h	NULL
about	NULL
18	NULL
%	NULL
and	NULL
24	NULL
%	NULL
of	NULL
the	NULL
Ratl-E1A	NULL
or	NULL
Ratl-Mye	NULL
cells	NULL
were	NULL
apoptotic	NULL
as	NULL
compared	NULL
to	NULL
3	NULL
%	NULL
of	NULL
Ratl-pMV7	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
cytotoxic	NULL
effect	NULL
of	NULL
IL-2	NULL
activated	NULL
killer	NULL
cells	NULL
towards	NULL
oncogene	NULL
expressing	NULL
Ratl	NULL
cells	NULL
does	NULL
not	NULL
require	NULL
TNF	NULL
or	NULL
CD95	NULL
ligand	NULL
We	NULL
used	NULL
a	NULL
neutralizing	NULL
antibody	NULL
that	NULL
blocks	NULL
both	NULL
soluble	NULL
and	NULL
transmembrane	NULL
forms	NULL
of	NULL
TNF	NULL
to	NULL
test	NULL
if	NULL
2183	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
2184	NULL
A	NULL
Adhesion	NULL
B	NULL
F-actin	NULL
polarization	NULL
C_	NULL
Phosphoinositide	NULL
hydrolysis	NULL
60	NULL
g	NULL
50	NULL
600	NULL
4	NULL
so	NULL
a	NULL
g	NULL
«	NULL
o	NULL
&	NULL
5	NULL
NK	NULL
cells	NULL
%	NULL
3	NULL
min	NULL
g	NULL
20	NULL
N	NULL
NK	NULL
cells+IL-2	NULL
E	NULL
200	NULL
E	NULL
12m	NULL
s	NULL
©	NULL
&	NULL
Rat	NULL
-	NULL
Ratl-	NULL
-	NULL
Ratl-EIA	NULL
-	NULL
Myo	NULL
Ratt	NULL
Ratl-KIA	NULL
--	NULL
Rati-Myc	NULL
Figure	NULL
3	NULL
-	NULL
NK	NULL
cell	NULL
adhesion	NULL
to	NULL
Ratl	NULL
,	NULL
Ratl-E1A	NULL
and	NULL
Ratl-Myc	NULL
fibroblast	NULL
monolayers	NULL
and	NULL
activation	NULL
of	NULL
NK	NULL
cell	NULL
cytolytic	NULL
machinery	NULL
.	NULL

(	NULL
a	NULL
)	NULL
NK	NULL
cell	NULL
adhesion	NULL
.	NULL

The	NULL
fibroblasts	NULL
were	NULL
seeded	NULL
on	NULL
96	NULL
well	NULL
plates	NULL
(	NULL
20	NULL
000	NULL
cells/well	NULL
)	NULL
and	NULL
grown	NULL
overnight	NULL
,	NULL
when	NULL
they	NULL
formed	NULL
a	NULL
confluent	NULL
layer	NULL
.	NULL

The	NULL
NK	NULL
cells	NULL
were	NULL
cultured	NULL
overnight	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IL-2	NULL
(	NULL
500	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
,	NULL
labelled	NULL
for	NULL
4	NULL
h	NULL
with	NULL
Na	NULL
[	NULL
®'Cr	NULL
]	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
mixed	NULL
with	NULL
targets	NULL
in	NULL
a	NULL
1:1	NULL
ratio	NULL
and	NULL
gently	NULL
centrifuged	NULL
onto	NULL
the	NULL
fibroblast	NULL
layer	NULL
.	NULL

Cells	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
for	NULL
15	NULL
min	NULL
,	NULL
then	NULL
the	NULL
cultures	NULL
were	NULL
carefully	NULL
washed	NULL
six	NULL
times	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
radioactivity	NULL
corresponding	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
bound	NULL
NK	NULL
cells	NULL
was	NULL
quantitated	NULL
from	NULL
the	NULL
cells	NULL
lysed	NULL
with	NULL
10	NULL
%	NULL
Triton-X-100	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
percentages	NULL
of	NULL
the	NULL
total	NULL
radioactivity	NULL
(	NULL
radioactivity	NULL
of	NULL
NK	NULL
cells	NULL
before	NULL
washings	NULL
)	NULL
and	NULL
represent	NULL
the	NULL
mean+s.d	NULL
.	NULL

of	NULL
six	NULL
identical	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
A	NULL
fluorescence	NULL
confocal	NULL
microscopy	NULL
image	NULL
(	NULL
400	NULL
x	NULL
)	NULL
of	NULL
a	NULL
rhodamin-phalloidin	NULL
stained	NULL
NK	NULL
cell	NULL
bound	NULL
to	NULL
Ratl	NULL
fibroblast	NULL
,	NULL
showing	NULL
prominent	NULL
F-actin	NULL
at	NULL
the	NULL
contact	NULL
area	NULL
.	NULL

For	NULL
assays	NULL
,	NULL
Ratl	NULL
,	NULL
Ratl-ElA	NULL
or	NULL
Ratl-Myc	NULL
target	NULL
cells	NULL
were	NULL
grown	NULL
overnight	NULL
on	NULL
coverslips	NULL
in	NULL
24	NULL
well	NULL
plates	NULL
(	NULL
10	NULL
000	NULL
cells/well	NULL
)	NULL
.	NULL

NK	NULL
cells	NULL
were	NULL
IL-2	NULL
activated	NULL
,	NULL
mixed	NULL
with	NULL
the	NULL
different	NULL
targets	NULL
,	NULL
centrifuged	NULL
and	NULL
incubated	NULL
for	NULL
30-60	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
after	NULL
which	NULL
the	NULL
coverslips	NULL
were	NULL
removed	NULL
,	NULL
fixed	NULL
in	NULL
3.5	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
and	NULL
stained	NULL
with	NULL
rhodamin-labelled	NULL
phalloidin	NULL
.	NULL

(	NULL
c	NULL
)	NULL
Induction	NULL
of	NULL
phosphoinositide	NULL
hydrolysis	NULL
in	NULL
NK	NULL
cells	NULL
by	NULL
different	NULL
Ratl	NULL
target	NULL
cells	NULL
.	NULL

The	NULL
*H-inositol	NULL
labelled	NULL
NK	NULL
cells	NULL
were	NULL
allowed	NULL
to	NULL
adhere	NULL
for	NULL
0	NULL
or	NULL
15	NULL
min	NULL
to	NULL
the	NULL
indicated	NULL
target	NULL
cells	NULL
,	NULL
after	NULL
which	NULL
the	NULL
amount	NULL
of	NULL
cellular	NULL
radioactive	NULL
inositol-P1	NULL
was	NULL
determined	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
identical	NULL
experiments	NULL
100	NULL
€	NULL
A4	NULL
80	NULL
<	NULL
u	NULL
®	NULL
®	NULL
``	NULL
C	NULL
3	NULL
60	NULL
s	NULL
~	NULL
]	NULL
3	NULL
a	NULL
40	NULL
[	NULL
5	NULL
]	NULL
C	NULL
-q	NULL
20	NULL
[	NULL
=	NULL
]	NULL
pawl	NULL
0	NULL
£	NULL
I	NULL
I	NULL
u	NULL
U	NULL
10	NULL
1	NULL
0.1	NULL
0	NULL
Anti-TNF	NULL
antibody	NULL
concentration	NULL
(	NULL
ug/ml	NULL
)	NULL
Figure	NULL
4	NULL
TNF-specific	NULL
blocking	NULL
antibody	NULL
does	NULL
not	NULL
inhibit	NULL
cell	NULL
death	NULL
induced	NULL
by	NULL
activated	NULL
NK	NULL
cells	NULL
.	NULL

Inhibition	NULL
of	NULL
cell	NULL
death	NULL
was	NULL
quantitated	NULL
by	NULL
measuring	NULL
the	NULL
relative	NULL
increase	NULL
of	NULL
OD540	NULL
value	NULL
in	NULL
the	NULL
MTT-assay	NULL
.	NULL

IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
blocking	NULL
antibody	NULL
against	NULL
TNF	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
incubated	NULL
with	NULL
equivalent	NULL
concentrations	NULL
of	NULL
mouse	NULL
IgG	NULL
.	NULL

After	NULL
the	NULL
incubation	NULL
,	NULL
NK	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
target	NULL
cells	NULL
in	NULL
4:1	NULL
ratio	NULL
and	NULL
MTT-assays	NULL
were	NULL
performed	NULL
.	NULL

Circles	NULL
represent	NULL
Ratl-E1A	NULL
cells	NULL
and	NULL
triangles	NULL
Ratl-Myc	NULL
cells	NULL
.	NULL

In	NULL
control	NULL
cultures	NULL
the	NULL
IgG	NULL
antibodies	NULL
inhibited	NULL
about	NULL
3-6	NULL
%	NULL
of	NULL
cell	NULL
deaths	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Squares	NULL
represent	NULL
the	NULL
survival	NULL
of	NULL
the	NULL
TNF-sensitive	NULL
WEHI-164§	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
used	NULL
to	NULL
control	NULL
the	NULL
blocking	NULL
capacity	NULL
of	NULL
the	NULL
anti-TNF	NULL
antibody	NULL
.	NULL

TNF	NULL
was	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
blocking	NULL
antibodies	NULL
prior	NULL
addition	NULL
to	NULL
the	NULL
WEHI-164	NULL
$	NULL
cells	NULL
in	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
TNF	NULL
contributed	NULL
to	NULL
the	NULL
cytotoxic	NULL
activity	NULL
of	NULL
NK	NULL
cells	NULL
(	NULL
Aversa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
blocking	NULL
efficiency	NULL
of	NULL
the	NULL
anti-TNF	NULL
antibody	NULL
was	NULL
controlled	NULL
in	NULL
TNF	NULL
cytotoxicity	NULL
assays	NULL
using	NULL
highly	NULL
TNF-sensitive	NULL
WEHI-164S8	NULL
cells	NULL
.	NULL

The	NULL
anti-TNF	NULL
antibody	NULL
did	NULL
not	NULL
have	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
death	NULL
of	NULL
Ratl-Myc	NULL
or	NULL
Ratl-ElA	NULL
cells	NULL
in	NULL
the	NULL
cocultures	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
but	NULL
it	NULL
completely	NULL
blocked	NULL
TNF-induced	NULL
death	NULL
of	NULL
WEHI-164S	NULL
cells	NULL
Western	NULL
blot	NULL
analyses	NULL
with	NULL
the	NULL
CD9S-antibody	NULL
show	NULL
that	NULL
Ratl	NULL
cells	NULL
express	NULL
CD95	NULL
(	NULL
Hueber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

To	NULL
test	NULL
if	NULL
Ratl	NULL
cells	NULL
were	NULL
sensitive	NULL
to	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
CD95L	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
soluble	NULL
CD95L	NULL
and	NULL
the	NULL
ensuing	NULL
apoptotic	NULL
cell	NULL
deaths	NULL
were	NULL
scored	NULL
by	NULL
time-lapse	NULL
videomicroscopy	NULL
.	NULL

Soluble	NULL
CD95L	NULL
did	NULL
not	NULL
induce	NULL
apoptosis	NULL
in	NULL
the	NULL
cultures	NULL
of	NULL
Ratl	NULL
or	NULL
Ratl-El1A	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
Rat1-Myc	NULL
cells	NULL
were	NULL
susceptible	NULL
to	NULL
apoptosis	NULL
by	NULL
CD9SL	NULL
(	NULL
Figure	NULL
5a	NULL
)	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
role	NULL
of	NULL
CD9SL	NULL
in	NULL
the	NULL
killer	NULL
cell	NULL
induced	NULL
death	NULL
of	NULL
Ratl-Myc	NULL
targets	NULL
,	NULL
we	NULL
used	NULL
IL-2	NULL
activated	NULL
killer	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
gid	NULL
mice	NULL
as	NULL
effectors	NULL
.	NULL

These	NULL
cells	NULL
have	NULL
a	NULL
loss-of-function	NULL
mutation	NULL
in	NULL
the	NULL
CD95SL-gene	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
we	NULL
used	NULL
killer	NULL
cells	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
normal	NULL
mice	NULL
of	NULL
the	NULL
same	NULL
strain	NULL
.	NULL

Both	NULL
the	NULL
normal	NULL
and	NULL
the	NULL
gid	NULL
mouse-derived	NULL
killer	NULL
cells	NULL
,	NULL
above	NULL
the	NULL
10:1	NULL
effector	NULL
cell	NULL
:	NULL
target	NULL
cell	NULL
ratio	NULL
,	NULL
killed	NULL
more	NULL
efficiently	NULL
Ratl-Mye	NULL
cells	NULL
than	NULL
Ratl	NULL
cells	NULL
(	NULL
Figure	NULL
5b	NULL
)	NULL
.	NULL

Discussion	NULL
Oncogenes	NULL
c-Myc	NULL
and	NULL
ElA	NULL
promote	NULL
cell	NULL
proliferation	NULL
but	NULL
exert	NULL
at	NULL
a	NULL
same	NULL
time	NULL
destructive	NULL
effects	NULL
for	NULL
cells	NULL
by	NULL
sensitizing	NULL
them	NULL
to	NULL
various	NULL
triggers	NULL
of	NULL
apoptosis	NULL
.	NULL

For	NULL
example	NULL
,	NULL
cells	NULL
which	NULL
survive	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
proapoptotic	NULL
cytokines	NULL
TNF	NULL
and	NULL
CD95L	NULL
,	NULL
die	NULL
by	NULL
these	NULL
cytokines	NULL
if	NULL
the	NULL
oncogenic	NULL
activity	NULL
of	NULL
c-Myc	NULL
is	NULL
turned	NULL
on	NULL
in	NULL
the	NULL
cells	NULL
(	NULL
Hueber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Klefstrom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

c-Myc	NULL
and	NULL
ElA	NULL
also	NULL
sensitize	NULL
cells	NULL
to	NULL
lysis	NULL
by	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
oncogene	NULL
expression	NULL
have	NULL
effects	NULL
on	NULL
the	NULL
target	NULL
cell	NULL
surface	NULL
which	NULL
may	NULL
facilitate	NULL
the	NULL
triggering	NULL
of	NULL
the	NULL
cytolytic	NULL
machinery	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
one	NULL
uncovered	NULL
mechanism	NULL
whereby	NULL
oncogenes	NULL
can	NULL
sensi-	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
A	NULL
Soluble	NULL
CDI5L	NULL
B	NULL
Normal	NULL
effector	NULL
cells	NULL
gid	NULL
effector	NULL
cells	NULL
200	NULL
100	NULL
100	NULL
tn	NULL
-o-	NULL
Ratl	NULL
3	NULL
-e-	NULL
Rat1-EIA	NULL
.	NULL

90	NULL
90	NULL
$	NULL
559	NULL
)	NULL
Gratin	NULL
E	NULL
=	NULL
arl-Mye	NULL
-	NULL
<	NULL
80	NULL
so	NULL
@	NULL
a	NULL
o	NULL
«	NULL
m	NULL
g	NULL
100	NULL
E	NULL
70	NULL
70	NULL
g	NULL
@	NULL
A	NULL
60	NULL
60	NULL
g	NULL
C	NULL
3	NULL
3	NULL
50	NULL
50	NULL
0	NULL
40	NULL
40	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
0	NULL
10	NULL
25	NULL
50	NULL
0	NULL
10	NULL
25	NULL
50	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
effector	NULL
cell	NULL
:	NULL
target	NULL
cell	NULL
Figure	NULL
5	NULL
-	NULL
c-Myc	NULL
renders	NULL
Rat	NULL
]	NULL
l	NULL
cells	NULL
sensitive	NULL
to	NULL
cytotoxic	NULL
effects	NULL
of	NULL
soluble	NULL
CD95L	NULL
(	NULL
a	NULL
)	NULL
and	NULL
also	NULL
of	NULL
CD95L-deficient	NULL
killer	NULL
cells	NULL
(	NULL
b	NULL
)	NULL
.	NULL

(	NULL
a	NULL
)	NULL
The	NULL
soluble	NULL
CD9S5L	NULL
(	NULL
100	NULL
ng/ml	NULL
,	NULL
Alexis	NULL
Corporation	NULL
)	NULL
induced	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
cultures	NULL
of	NULL
Ratl	NULL
,	NULL
Ratl-E1A	NULL
and	NULL
Ratl-Myc	NULL
cells	NULL
was	NULL
assayed	NULL
by	NULL
time-lapse	NULL
videomicroscopy	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Cytotoxicity	NULL
of	NULL
IL-2	NULL
activated	NULL
killer	NULL
cells	NULL
derived	NULL
from	NULL
normal	NULL
or	NULL
g/d	NULL
mice	NULL
towards	NULL
c-Myc	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
.	NULL

The	NULL
effector	NULL
cells	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
CD95L-deficient	NULL
g/d	NULL
mice	NULL
or	NULL
from	NULL
normal	NULL
mice	NULL
,	NULL
were	NULL
activated	NULL
for	NULL
18	NULL
h	NULL
with	NULL
IL-2	NULL
(	NULL
500	NULL
U/ml	NULL
!	NULL
)	NULL

prior	NULL
to	NULL
the	NULL
addition	NULL
on	NULL
target	NULL
cells	NULL
.	NULL

Cell	NULL
survival	NULL
of	NULL
Ratl	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
and	NULL
Ratl-Myc	NULL
(	NULL
triangles	NULL
)	NULL
cells	NULL
cocultured	NULL
for	NULL
48	NULL
h	NULL
with	NULL
the	NULL
IL-2	NULL
activated	NULL
killer	NULL
cells	NULL
at	NULL
different	NULL
effector-target	NULL
cell	NULL
ratios	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
MTT-assay	NULL
.	NULL

The	NULL
results	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
two	NULL
separate	NULL
experiments	NULL
tize	NULL
cells	NULL
to	NULL
NK	NULL
cell	NULL
mediated	NULL
lysis	NULL
yet	NULL
it	NULL
does	NULL
not	NULL
exclude	NULL
the	NULL
involvement	NULL
of	NULL
other	NULL
mechanisms	NULL
downstream	NULL
the	NULL
cytolytic	NULL
pathway	NULL
.	NULL

We	NULL
addressed	NULL
the	NULL
question	NULL
whether	NULL
a	NULL
link	NULL
exists	NULL
between	NULL
the	NULL
oncogene-induced	NULL
NK	NULL
cell	NULL
sensitivity	NULL
and	NULL
the	NULL
susceptibility	NULL
of	NULL
oncogene	NULL
expressing	NULL
cells	NULL
to	NULL
the	NULL
cytolytic	NULL
proteins	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

The	NULL
rat	NULL
fibroblasts	NULL
were	NULL
cocultured	NULL
with	NULL
human	NULL
NK	NULL
cells	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
species	NULL
difference	NULL
the	NULL
cytolytic	NULL
activity	NULL
of	NULL
human	NULL
NK	NULL
cells	NULL
could	NULL
not	NULL
be	NULL
affected	NULL
by	NULL
MHC	NULL
on	NULL
rodent	NULL
Ratl	NULL
cells	NULL
(	NULL
Gumperz	NULL
and	NULL
Parham	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
expected	NULL
that	NULL
NK	NULL
cells	NULL
would	NULL
recognize	NULL
both	NULL
parental	NULL
and	NULL
oncogene	NULL
expressing	NULL
target	NULL
cells	NULL
as	NULL
foreign	NULL
cells	NULL
and	NULL
expose	NULL
them	NULL
to	NULL
cytolytic	NULL
attack	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
IL-2	NULL
activated	NULL
NK	NULL
cells	NULL
bound	NULL
to	NULL
parental	NULL
and	NULL
oncogene-expressing	NULL
Ratl	NULL
cells	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
and	NULL
the	NULL
cytolysis-associated	NULL
,	NULL
F-actin	NULL
enriched	NULL
contact	NULL
sites	NULL
were	NULL
formed	NULL
.	NULL

These	NULL
NK	NULL
cells	NULL
were	NULL
also	NULL
cytolytically	NULL
activated	NULL
in	NULL
contact	NULL
with	NULL
resistant	NULL
parental	NULL
as	NULL
well	NULL
as	NULL
sensitive	NULL
oncoprotein	NULL
expressing	NULL
Ratl	NULL
cells	NULL
as	NULL
demonstrated	NULL
by	NULL
quantitative	NULL
analyses	NULL
of	NULL
phosphoinositide	NULL
hydrolysis	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
susceptibility	NULL
between	NULL
parental	NULL
and	NULL
oncoprotein	NULL
expressing	NULL
Ratl	NULL
cells	NULL
receded	NULL
within	NULL
the	NULL
post-triggering	NULL
phase	NULL
of	NULL
NK	NULL
cell-target	NULL
cell	NULL
interaction	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
our	NULL
results	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
recent	NULL
results	NULL
showing	NULL
that	NULL
EIA	NULL
expression	NULL
increases	NULL
the	NULL
sensitivity	NULL
of	NULL
NIH3T3	NULL
fibroblasts	NULL
to	NULL
cytotoxic	NULL
lymphocytes	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
the	NULL
type	NULL
of	NULL
target	NULL
cell	NULL
recognition	NULL
mechanism	NULL
used	NULL
(	NULL
Cook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
cell	NULL
death	NULL
was	NULL
determined	NULL
at	NULL
the	NULL
post-triggering	NULL
phase	NULL
,	NULL
we	NULL
found	NULL
that	NULL
both	NULL
the	NULL
EIA	NULL
and	NULL
c-Myc	NULL
overexpressing	NULL
Ratl	NULL
cells	NULL
were	NULL
more	NULL
sensitive	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
damaging	NULL
and	NULL
apoptosis-inducing	NULL
effects	NULL
of	NULL
the	NULL
purified	NULL
cytotoxic	NULL
granules	NULL
than	NULL
the	NULL
control	NULL
Ratl	NULL
cells	NULL
.	NULL

TNF	NULL
and	NULL
CD95L	NULL
,	NULL
both	NULL
expressed	NULL
by	NULL
NK	NULL
cells	NULL
,	NULL
can	NULL
also	NULL
mediate	NULL
NK	NULL
cell	NULL
induced	NULL
cell	NULL
death	NULL
.	NULL

However	NULL
,	NULL
our	NULL
experiments	NULL
with	NULL
the	NULL
blocking	NULL
antibodies	NULL
against	NULL
TNF	NULL
and	NULL
with	NULL
the	NULL
CD9SL-deficient	NULL
mouse	NULL
killer	NULL
cells	NULL
showed	NULL
that	NULL
the	NULL
block	NULL
or	NULL
absence	NULL
of	NULL
these	NULL
molecules	NULL
did	NULL
not	NULL
block	NULL
the	NULL
c-Myc	NULL
effect	NULL
on	NULL
cell	NULL
death	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
present	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
NK	NULL
cell	NULL
granules	NULL
were	NULL
the	NULL
primary	NULL
mediators	NULL
of	NULL
the	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
effects	NULL
towards	NULL
the	NULL
oncogene-expressing	NULL
targets	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
shown	NULL
that	NULL
cells	NULL
may	NULL
differ	NULL
in	NULL
their	NULL
susceptibility	NULL
to	NULL
the	NULL
lytic	NULL
effects	NULL
of	NULL
NK	NULL
cell	NULL
derived	NULL
granules	NULL
(	NULL
Chow	NULL
,	NULL
1990	NULL
;	NULL
Khalil	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
yet	NULL
the	NULL
factors	NULL
that	NULL
determine	NULL
the	NULL
susceptibility	NULL
have	NULL
not	NULL
been	NULL
identified	NULL
.	NULL

This	NULL
study	NULL
links	NULL
the	NULL
action	NULL
of	NULL
E1A	NULL
and	NULL
c-Myc	NULL
to	NULL
the	NULL
increased	NULL
susceptibility	NULL
of	NULL
cells	NULL
to	NULL
the	NULL
lytic	NULL
effects	NULL
of	NULL
the	NULL
granules	NULL
.	NULL

However	NULL
,	NULL
the	NULL
possible	NULL
interaction	NULL
mechanisms	NULL
between	NULL
granular	NULL
effector	NULL
proteins	NULL
and	NULL
c-Myc	NULL
or	NULL
EIA	NULL
remain	NULL
to	NULL
be	NULL
clarified	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
fibroblasts	NULL
by	NULL
growth	NULL
factors	NULL
increases	NULL
their	NULL
sensitivity	NULL
to	NULL
the	NULL
lethal	NULL
effects	NULL
of	NULL
purified	NULL
cytotoxic	NULL
granules	NULL
(	NULL
Khalil	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
cell	NULL
growth	NULL
promoting	NULL
functions	NULL
of	NULL
c-Mye	NULL
or	NULL
E1A	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
Ratl	NULL
cell	NULL
sensitivity	NULL
to	NULL
the	NULL
granule	NULL
proteins	NULL
.	NULL

Exposure	NULL
of	NULL
cells	NULL
to	NULL
perforin	NULL
and	NULL
granzyme	NULL
B	NULL
activates	NULL
prematurely	NULL
the	NULL
mitotic	NULL
cyclin-dependent	NULL
kinase	NULL
p3MACDC2	NULL
(	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
granule	NULL
proteins	NULL
and	NULL
c-Myc	NULL
or	NULL
E1A	NULL
co-operatively	NULL
activate	NULL
central	NULL
cell	NULL
cycle	NULL
molecules	NULL
which	NULL
may	NULL
,	NULL
when	NULL
activated	NULL
'out-of-phase	NULL
'	NULL
with	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
have	NULL
apoptotic	NULL
functions	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
granzymes	NULL
A	NULL
(	NULL
Irmler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
B	NULL
(	NULL
Darmon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Irmler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
are	NULL
capable	NULL
of	NULL
activating	NULL
cellular	NULL
caspases	NULL
,	NULL
on	NULL
which	NULL
most	NULL
if	NULL
not	NULL
all	NULL
types	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
pathways	NULL
converge	NULL
.	NULL

Overexpression	NULL
of	NULL
c-Myc	NULL
or	NULL
ElA	NULL
could	NULL
increase	NULL
the	NULL
expression	NULL
or	NULL
lower	NULL
the	NULL
threshold	NULL
of	NULL
activation	NULL
of	NULL
these	NULL
basic	NULL
effector	NULL
proteins	NULL
of	NULL
the	NULL
apoptotic	NULL
machinery	NULL
.	NULL

Indeed	NULL
,	NULL
extracts	NULL
from	NULL
ElA	NULL
expressing	NULL
cells	NULL
but	NULL
not	NULL
from	NULL
normal	NULL
cells	NULL
spontaneously	NULL
activate	NULL
caspases	NULL
in	NULL
a	NULL
cell-free	NULL
system	NULL
(	NULL
Fearn-head	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
composition	NULL
of	NULL
this	NULL
oncogene-generated	NULL
activity	NULL
is	NULL
as	NULL
yet	NULL
uncharacterized	NULL
,	NULL
but	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
it	NULL
involves	NULL
central	NULL
molecules	NULL
of	NULL
apoptosomes	NULL
-	NULL
multiprotein	NULL
assemblies	NULL
thought	NULL
to	NULL
be	NULL
crucial	NULL
sites	NULL
of	NULL
caspase	NULL
activation	NULL
in	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
activation	NULL
of	NULL
caspase	NULL
9	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
protein	NULL
complex	NULL
involving	NULL
the	NULL
nematode	NULL
Ced4-like	NULL
protein	NULL
Apaf-1	NULL
,	NULL
mitochondria-	NULL
2185	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
2186	NULL
derived	NULL
holo-cytochrome	NULL
c	NULL
and	NULL
deoxyadenosine	NULL
tripho-sphate	NULL
(	NULL
Li	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Oncogenes	NULL
could	NULL
prime	NULL
apoptosomes	NULL
either	NULL
by	NULL
increasing	NULL
the	NULL
level	NULL
of	NULL
activators	NULL
or	NULL
decreasing	NULL
the	NULL
level	NULL
of	NULL
suppressor	NULL
proteins	NULL
in	NULL
these	NULL
assemblies	NULL
.	NULL

Therefore	NULL
,	NULL
sensitivity	NULL
of	NULL
oncogene	NULL
expressing	NULL
cells	NULL
to	NULL
proapoptotic	NULL
insults	NULL
like	NULL
TNF	NULL
receptor	NULL
or	NULL
Fas	NULL
ligation	NULL
,	NULL
cytotoxic	NULL
drugs	NULL
or	NULL
,	NULL
as	NULL
we	NULL
show	NULL
here	NULL
,	NULL
to	NULL
cytotoxic	NULL
granules	NULL
may	NULL
in	NULL
general	NULL
reflect	NULL
the	NULL
increased	NULL
readiness	NULL
of	NULL
apoptosomes	NULL
to	NULL
fire	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
noted	NULL
that	NULL
the	NULL
ElA-induced	NULL
NK	NULL
-sensitivity	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
adenoviral	NULL
anti-apoptotic	NULL
protein	NULL
E1B19K	NULL
,	NULL
which	NULL
is	NULL
a	NULL
viral	NULL
analogue	NULL
of	NULL
Bcl2	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
available	NULL
data	NULL
showing	NULL
that	NULL
also	NULL
Bel2	NULL
is	NULL
unable	NULL
to	NULL
protect	NULL
cells	NULL
from	NULL
NK-lysis	NULL
(	NULL
Sutton	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
c-Myc	NULL
induced	NULL
susceptibility	NULL
to	NULL
TNF	NULL
or	NULL
CD95L	NULL
mediated	NULL
killing	NULL
is	NULL
inhibited	NULL
by	NULL
Bcel2	NULL
in	NULL
Ratl	NULL
cells	NULL
(	NULL
Hueber	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Klefstrom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
data	NULL
argue	NULL
that	NULL
c-Mye	NULL
and	NULL
EIA	NULL
induce	NULL
sensitivity	NULL
to	NULL
at	NULL
least	NULL
two	NULL
types	NULL
of	NULL
apoptotic	NULL
path-ways	NULL
:	NULL
(	NULL
i	NULL
)	NULL
to	NULL
the	NULL
death	NULL
receptor-dependent	NULL
pathway	NULL
which	NULL
is	NULL
upstream	NULL
of	NULL
Bcl2	NULL
or	NULL
E1B19K	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
to	NULL
the	NULL
granule-dependent	NULL
pathway	NULL
which	NULL
is	NULL
either	NULL
separate	NULL
of	NULL
former	NULL
or	NULL
downstream	NULL
of	NULL
it	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
anti-apoptotic	NULL
proteins	NULL
,	NULL
the	NULL
loss-of	NULL
wild-type	NULL
p53	NULL
activity	NULL
renders	NULL
cells	NULL
resistant	NULL
to	NULL
various	NULL
inducers	NULL
of	NULL
apoptosis-providing	NULL
a	NULL
plausible	NULL
explanation	NULL
for	NULL
the	NULL
commoness	NULL
of	NULL
p53	NULL
mutations	NULL
in	NULL
cancer	NULL
(	NULL
Levine	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
present	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
wild-type	NULL
activity	NULL
of	NULL
p53	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
c-Myc	NULL
or	NULL
EIA	NULL
induced	NULL
sensitivity	NULL
to	NULL
the	NULL
cytotoxic	NULL
granule-induced	NULL
death	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
noticed	NULL
that	NULL
mouse	NULL
embryonic	NULL
fibroblasts	NULL
deficient	NULL
in	NULL
p53	NULL
or	NULL
Friend	NULL
Leukemia	NULL
Virus	NULL
induced	NULL
cell	NULL
lines	NULL
not	NULL
expressing	NULL
p53	NULL
as	NULL
a	NULL
result	NULL
of	NULL
viral	NULL
integration	NULL
in	NULL
both	NULL
p53	NULL
alleles	NULL
are	NULL
completely	NULL
susceptible	NULL
to	NULL
granzyme	NULL
B	NULL
and	NULL
perforin	NULL
mediated	NULL
apoptosis	NULL
(	NULL
L	NULL
Shi	NULL
and	NULL
AH	NULL
Greenberg	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Apparently	NULL
the	NULL
cytolytic	NULL
factors	NULL
of	NULL
cytotoxic	NULL
granules	NULL
,	NULL
once	NULL
activated	NULL
by	NULL
oncogenes	NULL
,	NULL
bypass	NULL
the	NULL
common	NULL
blocks	NULL
of	NULL
apoptosis	NULL
in	NULL
tumor	NULL
cells	NULL
or	NULL
in	NULL
cells	NULL
infected	NULL
with	NULL
oncogenic	NULL
viruses	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
dissociate	NULL
the	NULL
triggering	NULL
of	NULL
the	NULL
cytolytic	NULL
machinery	NULL
from	NULL
the	NULL
cytolytic	NULL
action	NULL
of	NULL
the	NULL
NK	NULL
cells	NULL
.	NULL

We	NULL
hypothetize	NULL
that	NULL
at	NULL
least	NULL
in	NULL
some	NULL
cases	NULL
the	NULL
triggering	NULL
of	NULL
the	NULL
cytolytic	NULL
machinery	NULL
of	NULL
NK	NULL
cells	NULL
delivers	NULL
a	NULL
cytolytic	NULL
challenge	NULL
rather	NULL
than	NULL
a	NULL
cytolytic	NULL
hit	NULL
to	NULL
target	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
exocytosis	NULL
of	NULL
the	NULL
NK	NULL
cell	NULL
granules	NULL
does	NULL
not	NULL
necessarily	NULL
represent	NULL
the	NULL
point-of-no-return	NULL
to	NULL
the	NULL
target	NULL
cells	NULL
The	NULL
target	NULL
cell	NULL
specific	NULL
determinants	NULL
such	NULL
as	NULL
oncogenes	NULL
can	NULL
play	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
cytotoxicity	NULL
of	NULL
the	NULL
granules	NULL
.	NULL

This	NULL
mechanism	NULL
would	NULL
perfect	NULL
the	NULL
selectivity	NULL
of	NULL
the	NULL
cytotoxic	NULL
action	NULL
of	NULL
NK	NULL
cells	NULL
;	NULL
it	NULL
protects	NULL
normal	NULL
cells	NULL
and	NULL
enhances	NULL
the	NULL
cytolytic	NULL
action	NULL
towards	NULL
the	NULL
virus-infected	NULL
and	NULL
cancer	NULL
cells	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Target	NULL
cells	NULL
and	NULL
gene	NULL
transfer	NULL
Rat	NULL
fibroblast	NULL
Ratl	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
.	NULL

The	NULL
cells	NULL
containing	NULL
expression	NULL
constructs	NULL
were	NULL
grown	NULL
periodically	NULL
in	NULL
selection	NULL
medium	NULL
.	NULL

Ratl	NULL
cells	NULL
and	NULL
Ratl-Myc	NULL
clone	NULL
26	NULL
cells	NULL
have	NULL
been	NULL
described	NULL
earlier	NULL
(	NULL
Evan	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Ratl	NULL
EIA	NULL
clone	NULL
64	NULL
cells	NULL
expressing	NULL
128	NULL
EIA	NULL
and	NULL
Ratl-E1AE1BI9K	NULL
cells	NULL
expressing	NULL
128	NULL
ElA	NULL
and	NULL
19	NULL
kDa	NULL
E1B	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
Abdallah	NULL
Fanidi	NULL
.	NULL

Our	NULL
clone	NULL
of	NULL
WEHI-1648	NULL
cells	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
Marja	NULL
Jiittel4	NULL
.	NULL

The	NULL
p53Cter	NULL
DNA	NULL
fragment	NULL
encoding	NULL
the	NULL
carboxyterminal	NULL
302-390	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
murine	NULL
p53	NULL
was	NULL
cloned	NULL
into	NULL
pBabe-Hygro	NULL
retroviral	NULL
vector	NULL
and	NULL
introduced	NULL
by	NULL
retroviral	NULL
infection	NULL
into	NULL
Ratl	NULL
,	NULL
Ratl-Myc	NULL
clone	NULL
26	NULL
and	NULL
Ratl-ElA	NULL
clone	NULL
64	NULL
cells	NULL
.	NULL

The	NULL
infected	NULL
cells	NULL
were	NULL
selected	NULL
in	NULL
400	NULL
ug/ml	NULL
Hygromycin	NULL
B	NULL
and	NULL
the	NULL
resulting	NULL
clones	NULL
in	NULL
each	NULL
case	NULL
were	NULL
pooled	NULL
for	NULL
the	NULL
assays	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
p53Cter	NULL
in	NULL
our	NULL
clones	NULL
was	NULL
verified	NULL
by	NULL
Western	NULL
blotting	NULL
using	NULL
the	NULL
p53-specific	NULL
Pab	NULL
421	NULL
antibody	NULL
.	NULL

Isolation	NULL
of	NULL
effector	NULL
cells	NULL
The	NULL
human	NULL
NK	NULL
cells	NULL
were	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Timonen	NULL
and	NULL
Saksela	NULL
,	NULL
1980	NULL
)	NULL
.	NULL

In	NULL
short	NULL
,	NULL
leukocyte	NULL
rich	NULL
buffy	NULL
coats	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Finnish	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
.	NULL

The	NULL
mononuclear	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
Ficoll-Isopaque	NULL
density-gradient	NULL
centrifugation	NULL
(	NULL
Pharmacia	NULL
)	NULL
followed	NULL
by	NULL
filtration	NULL
through	NULL
nylon-wool	NULL
columns	NULL
to	NULL
remove	NULL
adherent	NULL
cells	NULL
.	NULL

NK	NULL
cells	NULL
were	NULL
further	NULL
enriched	NULL
by	NULL
two	NULL
step	NULL
Percoll	NULL
density	NULL
gradient	NULL
centrifugation	NULL
followed	NULL
by	NULL
immunomagnetic	NULL
removal	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
(	NULL
CD3-	NULL
,	NULL
CD19-	NULL
,	NULL
CD14-Dynabeads	NULL
)	NULL
.	NULL

In	NULL
FACS	NULL
analysis	NULL
90+	NULL
5	NULL
%	NULL
of	NULL
the	NULL
remaining	NULL
cells	NULL
were	NULL
CD56	NULL
positive	NULL
and	NULL
CD3	NULL
negative	NULL
NK	NULL
cells	NULL
with	NULL
less	NULL
than	NULL
5	NULL
%	NULL
contaminating	NULL
T	NULL
or	NULL
B	NULL
cells	NULL
or	NULL
monocytes	NULL
.	NULL

Mouse	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
spleens	NULL
of	NULL
9	NULL
week-old	NULL
C3H/Hej	NULL
mice	NULL
or	NULL
of	NULL
same	NULL
age	NULL
C3H/Hej	NULL
gid	NULL
mice	NULL
.	NULL

The	NULL
mice-strains	NULL
were	NULL
obtained	NULL
from	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
.	NULL

Isolation	NULL
of	NULL
cytoplasmic	NULL
granules	NULL
from	NULL
RNK	NULL
cells	NULL
Rat	NULL
natural	NULL
killer	NULL
(	NULL
RNK	NULL
)	NULL
large	NULL
granular	NULL
lymphocytic	NULL
leukemia	NULL
cell	NULL
granules	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
(	NULL
Shi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

One	NULL
ml	NULL
of	NULL
granules	NULL
was	NULL
equivalent	NULL
to	NULL
1x	NULL
10°	NULL
RNK	NULL
cells	NULL
.	NULL

MTT	NULL
Cell	NULL
viability	NULL
assay	NULL
Cell	NULL
survival	NULL
was	NULL
quantitated	NULL
by	NULL
a	NULL
colorimetric	NULL
MTT	NULL
assay	NULL
,	NULL
which	NULL
measures	NULL
mitochondrial	NULL
activity	NULL
in	NULL
viable	NULL
cells	NULL
.	NULL

For	NULL
assays	NULL
5000	NULL
target	NULL
cells/well	NULL
were	NULL
seeded	NULL
on	NULL
96-well	NULL
plates	NULL
(	NULL
Nunc	NULL
)	NULL
.	NULL

After	NULL
overnight	NULL
adherence	NULL
,	NULL
the	NULL
effector	NULL
cells	NULL
were	NULL
added	NULL
on	NULL
the	NULL
target	NULL
cells	NULL
.	NULL

Each	NULL
assay	NULL
was	NULL
set	NULL
up	NULL
in	NULL
triplicate	NULL
wells	NULL
.	NULL

After	NULL
a	NULL
48	NULL
h	NULL
incubation	NULL
period	NULL
10	NULL
ul	NULL
of	NULL
MTT	NULL
from	NULL
a	NULL
5	NULL
mg/ml	NULL
stock	NULL
solution	NULL
was	NULL
added	NULL
into	NULL
each	NULL
well	NULL
and	NULL
the	NULL
plates	NULL
were	NULL
further	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
by	NULL
adding	NULL
100	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
mm	NULL
HCl	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
formazan	NULL
products	NULL
were	NULL
solubilized	NULL
overnight	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
humid	NULL
atmosphere	NULL
,	NULL
after	NULL
which	NULL
the	NULL
absorbance	NULL
at	NULL
540	NULL
nm	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
Multiscan	NULL
microtiter	NULL
plate	NULL
reader	NULL
(	NULL
Labsystems	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
surviving	NULL
cells	NULL
was	NULL
defined	NULL
using	NULL
the	NULL
formula	NULL
[	NULL
(	NULL
experimental-blank1	NULL
)	NULL
/	NULL
(	NULL
control-blank2	NULL
)	NULL
]	NULL
x	NULL
100	NULL
where	NULL
the	NULL
'experimental	NULL
'	NULL
is	NULL
the	NULL
absorbance	NULL
value	NULL
of	NULL
effector-target	NULL
cell	NULL
cocultures	NULL
and	NULL
'blank1	NULL
'	NULL
the	NULL
absorbance	NULL
of	NULL
the	NULL
effector	NULL
cells	NULL
.	NULL

The	NULL
'control	NULL
'	NULL
is	NULL
the	NULL
absorbance	NULL
value	NULL
of	NULL
the	NULL
target	NULL
cells	NULL
and	NULL
'blank	NULL
?	NULL
'	NULL

of	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Tunel	NULL
staining	NULL
of	NULL
apoptosis	NULL
For	NULL
TUNEL-staining	NULL
,	NULL
target	NULL
cells	NULL
were	NULL
grown	NULL
on	NULL
uncoated	NULL
coverslips	NULL
in	NULL
24-well	NULL
plates	NULL
.	NULL

The	NULL
effector	NULL
cells	NULL
were	NULL
added	NULL
on	NULL
the	NULL
target	NULL
cells	NULL
at	NULL
ratio	NULL
1:1	NULL
and	NULL
after	NULL
incubation	NULL
the	NULL
coverslips	NULL
were	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
formaldehyde	NULL
.	NULL

The	NULL
TUNEL	NULL
staining	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
Klefstrom	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Assays	NULL
of	NULL
granule	NULL
cytotoxicity	NULL
For	NULL
trypan-blue	NULL
exclusion	NULL
assays	NULL
,	NULL
50	NULL
000	NULL
cells/well	NULL
were	NULL
seeded	NULL
on	NULL
96-well	NULL
plates	NULL
.	NULL

After	NULL
overnight	NULL
adherence	NULL
,	NULL
the	NULL
culture	NULL
medium	NULL
was	NULL
replaced	NULL
with	NULL
HH-BSA	NULL
(	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
supplemented	NULL
with	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
2	NULL
mM	NULL
CaCl	NULL
,	NULL
and	NULL
4	NULL
mg/ml	NULL
BSA	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

The	NULL
RNK	NULL
granules	NULL
were	NULL
diluted	NULL
in	NULL
HE-Na	NULL
buffer	NULL
(	NULL
10	NULL
mm	NULL
HEPES	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
140	NULL
mm	NULL
NaCl	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
target	NULL
cells	NULL
.	NULL

At	NULL
defined	NULL
time-points	NULL
both	NULL
the	NULL
adherent	NULL
and	NULL
non-adherent	NULL
cells	NULL
of	NULL
each	NULL
well	NULL
were	NULL
pooled	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
trypan	NULL
blue	NULL
staining	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
microscopy	NULL
.	NULL

Each	NULL
assay	NULL
was	NULL
set	NULL
up	NULL
in	NULL
duplicate	NULL
wells	NULL
.	NULL

For	NULL
propidium-iodide	NULL
(	NULL
PI	NULL
)	NULL
staining	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
on	NULL
0.05	NULL
%	NULL
poly-L-lysine-coated	NULL
coverslips	NULL
in	NULL
35-mm	NULL
dishes	NULL
for	NULL
2	NULL
days	NULL
prior	NULL
to	NULL
the	NULL
assay	NULL
.	NULL

The	NULL
RNK	NULL
granules	NULL
were	NULL
diluted	NULL
in	NULL
HE-Na	NULL
buffer	NULL
and	NULL
added	NULL
to	NULL
the	NULL
target	NULL
cell	NULL
cultures	NULL
whose	NULL
culture	NULL
medium	NULL
,	NULL
prior	NULL
granule-addition	NULL
,	NULL
was	NULL
replaced	NULL
with	NULL
HH-BSA	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
coverslips	NULL
were	NULL
picked	NULL
up	NULL
and	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
formaldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

To	NULL
score	NULL
apoptotic	NULL
cells	NULL
on	NULL
the	NULL
coverslips	NULL
,	NULL
the	NULL
fixed	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
in	NULL
PI	NULL
solution	NULL
(	NULL
50	NULL
ug/ml	NULL
PI	NULL
and	NULL
1	NULL
mg/ml	NULL
RNaseA	NULL
in	NULL
PBS	NULL
)	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
mounted	NULL
with	NULL
glycerol-PBS	NULL
for	NULL
immunofluorescence	NULL
microscopy	NULL
.	NULL

The	NULL
condensed	NULL
and	NULL
fragmented	NULL
apoptotic	NULL
nuclei	NULL
formed	NULL
bright	NULL
fluorescent	NULL
images	NULL
and	NULL
were	NULL
distinguishable	NULL
from	NULL
the	NULL
round	NULL
and	NULL
dim	NULL
normal	NULL
nuclei	NULL
.	NULL

The	NULL
ratio	NULL
of	NULL
apoptotic	NULL
and	NULL
non-apoptotic	NULL
nuclei	NULL
was	NULL
scored	NULL
by	NULL
counting	NULL
200-1000	NULL
nuclei	NULL
per	NULL
coverslip	NULL
.	NULL

Generation	NULL
of	NULL
inositolphosphates	NULL
The	NULL
generation	NULL
of	NULL
inositolphosphates	NULL
in	NULL
NK	NULL
cells	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
Stahls	NULL
and	NULL
Carpen	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Purified	NULL
References	NULL
Arase	NULL
H	NULL
,	NULL
Arase	NULL
N	NULL
and	NULL
Saito	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
1235-1238	NULL
.	NULL

Atkinson	NULL
EA	NULL
,	NULL
Gerrard	NULL
JM	NULL
,	NULL
Hildes	NULL
GE	NULL
and	NULL
Greenberg	NULL
AH	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
47	NULL
,	NULL
39-48	NULL
.	NULL

Aversa	NULL
G	NULL
,	NULL
Punnonen	NULL
J	NULL
and	NULL
de	NULL
Vries	NULL
JE	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
177	NULL
,	NULL
1575-1585	NULL
.	NULL

Berke	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
735-773	NULL
.	NULL

Brutkiewicz	NULL
RR	NULL
and	NULL
Welsh	NULL
RM	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
3967	NULL
3971	NULL
.	NULL

Chen	NULL
MJ	NULL
,	NULL
Holskin	NULL
B	NULL
,	NULL
Strickler	NULL
J	NULL
,	NULL
Gorniak	NULL
J	NULL
,	NULL
Clark	NULL
MA	NULL
,	NULL
Johnson	NULL
PJ	NULL
,	NULL
Mitcho	NULL
M	NULL
and	NULL
Shalloway	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
330	NULL
,	NULL
581-583	NULL
.	NULL

Chow	NULL
DA	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

,	NULL
127	NULL
,	NULL
172-186	NULL
.	NULL

Chow	NULL
SC	NULL
and	NULL
Jondal	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Immunology	NULL
,	NULL
70	NULL
,	NULL
106-110	NULL
.	NULL

Cook	NULL
JL	NULL
,	NULL
May	NULL
DL	NULL
,	NULL
Wilson	NULL
BA	NULL
,	NULL
Holskin	NULL
B	NULL
,	NULL
Chen	NULL
MJ	NULL
,	NULL
Shalloway	NULL
D	NULL
and	NULL
Walker	NULL
TA	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
142	NULL
,	NULL
4527-4534	NULL
.	NULL

Cook	NULL
JL	NULL
,	NULL
Potter	NULL
TA	NULL
,	NULL
Bellgrau	NULL
D	NULL
and	NULL
Routes	NULL
BA	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
13	NULL
,	NULL
$	NULL
33	NULL
Cuomo	NULL
L	NULL
,	NULL
Zhang	NULL
QJ	NULL
,	NULL
Lombardi	NULL
L	NULL
,	NULL
Torsteindottir	NULL
S	NULL
,	NULL
Klein	NULL
G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
and	NULL
Masucci	NULL
MG.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
53	NULL
,	NULL
1008-1012	NULL
.	NULL

Darmon	NULL
AJ	NULL
,	NULL
Nicholson	NULL
DW	NULL
and	NULL
Bleackley	NULL
RC	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
377	NULL
,	NULL
446-448	NULL
.	NULL

Debbas	NULL
M	NULL
and	NULL
White	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
546-554	NULL
.	NULL

Evan	NULL
GI	NULL
,	NULL
Wyllie	NULL
AH	NULL
,	NULL
Gilbert	NULL
CS	NULL
,	NULL
Littlewood	NULL
TD	NULL
,	NULL
Land	NULL
H	NULL
,	NULL
Brooks	NULL
M	NULL
,	NULL
Waters	NULL
CM	NULL
,	NULL
Penn	NULL
LZ	NULL
and	NULL
Hancock	NULL
DC	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
69	NULL
,	NULL
119-128	NULL
.	NULL

Fearnhead	NULL
HO	NULL
,	NULL
McCurrach	NULL
ME	NULL
,	NULL
O'Neill	NULL
J	NULL
,	NULL
Zhang	NULL
K	NULL
,	NULL
Lowe	NULL
SW	NULL
and	NULL
Lazebnik	NULL
YA	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
11	NULL
,	NULL
1266-1276	NULL
.	NULL

Griffiths	NULL
GM	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
343-348	NULL
.	NULL

Gumperz	NULL
JE	NULL
and	NULL
Parham	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
378	NULL
,	NULL
245-248.	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
NK	NULL
cells	NULL
(	NULL
10x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
incubated	NULL
for	NULL
20	NULL
h	NULL
in	NULL
inositol	NULL
free	NULL
culture	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
sine	NULL
inositol	NULL
,	NULL
Gibco	NULL
)	NULL
,	NULL
containing	NULL
1	NULL
%	NULL
of	NULL
HSA	NULL
,	NULL
300	NULL
IU/ml	NULL
IL-2	NULL
and	NULL
35	NULL
uCi/ml	NULL
[	NULL
HJinositol	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
kept	NULL
thereafter	NULL
in	NULL
inositol-free	NULL
culture	NULL
medium	NULL
containing	NULL
1	NULL
%	NULL
HSA	NULL
and	NULL
10	NULL
mM	NULL
LiCl	NULL
to	NULL
inhibit	NULL
the	NULL
activity	NULL
of	NULL
inositol-1-phosphate	NULL
phosphatase	NULL
.	NULL

Target	NULL
cells	NULL
(	NULL
7x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
'	NULL
H-inositol	NULL
labelled	NULL
NK	NULL
cells	NULL
in	NULL
a	NULL
1:1	NULL
ratio	NULL
after	NULL
which	NULL
the	NULL
cell	NULL
suspensions	NULL
were	NULL
pelleted	NULL
by	NULL
gentle	NULL
centrifugation	NULL
and	NULL
analysed	NULL
immediately	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
or	NULL
after	NULL
a	NULL
15	NULL
min	NULL
incubation	NULL
at	NULL
37°C	NULL
.	NULL

Inositolphosphate	NULL
metabolism	NULL
was	NULL
terminated	NULL
by	NULL
adding	NULL
methanol/chloro-form	NULL
(	NULL
2:1	NULL
)	NULL
followed	NULL
by	NULL
chloroform/water	NULL
(	NULL
1:1	NULL
)	NULL
to	NULL
the	NULL
cell	NULL
suspensions	NULL
.	NULL

The	NULL
water-soluble	NULL
inositolphosphates	NULL
were	NULL
separated	NULL
and	NULL
fractionated	NULL
on	NULL
MonoQ	NULL
anion-exchange	NULL
(	NULL
FPLC	NULL
)	NULL
system	NULL
(	NULL
Pharmacia	NULL
)	NULL
with	NULL
a	NULL
continuous	NULL
gradient	NULL
of	NULL
0-O0.1	NULL
M	NULL
ammonium	NULL
formate	NULL
.	NULL

One	NULL
ml	NULL
fractions	NULL
were	NULL
collected	NULL
and	NULL
the	NULL
radioactivity	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
beta	NULL
counter	NULL
(	NULL
LKB-Wallac	NULL
)	NULL
.	NULL

Acknowledgements	NULL
We	NULL
wish	NULL
to	NULL
thank	NULL
Dr	NULL
Olli	NULL
Carpen	NULL
for	NULL
useful	NULL
discussions	NULL
and	NULL
expert	NULL
help	NULL
in	NULL
confocal	NULL
microscopy	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Finnish	NULL
Cancer	NULL
Organizations	NULL
,	NULL
the	NULL
Finnish	NULL
Academy	NULL
,	NULL
Emil	NULL
Aaltonen	NULL
,	NULL
Maud	NULL
Kuistila	NULL
,	NULL
Sigrid	NULL
Juselius	NULL
,	NULL
Farmos	NULL
,	NULL
Finnish	NULL
Cultural	NULL
Foundations	NULL
and	NULL
European	NULL
Molecular	NULL
Biology	NULL
Organization	NULL
.	NULL

Helander	NULL
TS	NULL
,	NULL
Carpen	NULL
O	NULL
,	NULL
Turunen	NULL
O	NULL
,	NULL
Kovanen	NULL
PE	NULL
,	NULL
Vaheri	NULL
A	NULL
and	NULL
Timonen	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
382	NULL
,	NULL
265-267	NULL
.	NULL

Hueber	NULL
AO	NULL
,	NULL
Zornig	NULL
M	NULL
,	NULL
Lyon	NULL
D	NULL
,	NULL
Suda	NULL
T	NULL
,	NULL
Nagata	NULL
S	NULL
and	NULL
Evan	NULL
GI	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
278	NULL
,	NULL
1305-1309	NULL
.	NULL

Irmler	NULL
M	NULL
,	NULL
Hertig	NULL
S	NULL
,	NULL
MacDonald	NULL
HR	NULL
,	NULL
Sadoul	NULL
R	NULL
,	NULL
Becherer	NULL
JD	NULL
,	NULL
Proudfoot	NULL
A	NULL
,	NULL
Solari	NULL
R	NULL
and	NULL
Tschopp	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
1917-1922	NULL
.	NULL

Jans	NULL
DA	NULL
,	NULL
Jans	NULL
P	NULL
,	NULL
Briggs	NULL
LJ	NULL
,	NULL
Sutton	NULL
V	NULL
and	NULL
Trapani	NULL
JA	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
271	NULL
,	NULL
30781-30789	NULL
.	NULL

Khalil	NULL
N	NULL
,	NULL
Battistuzzi	NULL
SC	NULL
,	NULL
Kraut	NULL
RP	NULL
,	NULL
Schwarz	NULL
LC	NULL
and	NULL
Greenberg	NULL
AH	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
145	NULL
,	NULL
1286-1292	NULL
.	NULL

Klefstrom	NULL
J	NULL
,	NULL
Arighi	NULL
E	NULL
,	NULL
Littlewood	NULL
T	NULL
,	NULL
Jiittel4	NULL
M	NULL
,	NULL
Saksela	NULL
E	NULL
,	NULL
Evan	NULL
G	NULL
and	NULL
Alitalo	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
7382-7392	NULL
.	NULL

Klefstrom	NULL
J	NULL
,	NULL
Vastrik	NULL
I	NULL
,	NULL
Saksela	NULL
E	NULL
,	NULL
Valle	NULL
J	NULL
,	NULL
Eilers	NULL
M	NULL
and	NULL
Alitalo	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
,	NULL
5442-5450	NULL
.	NULL

La	NULL
Cava	NULL
A	NULL
,	NULL
Carbone	NULL
E	NULL
,	NULL
Moscarella	NULL
A	NULL
,	NULL
Barcova	NULL
M	NULL
,	NULL
Salzano	NULL
S	NULL
,	NULL
Zappacosta	NULL
S	NULL
and	NULL
Fontana	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
58	NULL
,	NULL
123-128	NULL
.	NULL

Lanier	NULL
LL	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Immunity	NULL
,	NULL
6	NULL
,	NULL
371-378	NULL
.	NULL

Levine	NULL
AJ	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
88	NULL
,	NULL
323-331	NULL
.	NULL

Li	NULL
P	NULL
,	NULL
Nijhawan	NULL
D	NULL
,	NULL
Budihardjo	NULL
I	NULL
,	NULL
Srinivasula	NULL
SM	NULL
,	NULL
Ahmad	NULL
M	NULL
,	NULL
Alnerari	NULL
ES	NULL
and	NULL
Wang	NULL
X	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
91	NULL
,	NULL
479-489	NULL
.	NULL

Ljunggren	NULL
HG	NULL
and	NULL
Kirre	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
11	NULL
,	NULL
237-240	NULL
.	NULL

Peltenburg	NULL
LT	NULL
,	NULL
Steegenga	NULL
WT	NULL
,	NULL
Kruse	NULL
KM	NULL
and	NULL
Schrier	NULL
PI	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
22	NULL
,	NULL
2737-2740	NULL
.	NULL

Raulet	NULL
DH	NULL
and	NULL
Held	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
,	NULL
82	NULL
,	NULL
697-700	NULL
.	NULL

Shaulian	NULL
E	NULL
,	NULL
Haviv	NULL
I	NULL
,	NULL
Shaul	NULL
Y	NULL
and	NULL
Oren	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
,	NULL
671-680	NULL
.	NULL

Shaulian	NULL
E	NULL
,	NULL
Zauberman	NULL
A	NULL
,	NULL
Ginsberg	NULL
D	NULL
and	NULL
Oren	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
5581-5592	NULL
.	NULL

2187	NULL
c-Myc	NULL
and	NULL
ELA	NULL
induced	NULL
sensitivity	NULL
to	NULL
NK	NULL
cell	NULL
cytotoxic	NULL
granules	NULL
J	NULL
Klefstrom	NULL
et	NULL
al	NULL
2188	NULL
Shi	NULL
L	NULL
,	NULL
Chen	NULL
G	NULL
,	NULL
MacDonald	NULL
G	NULL
,	NULL
Bergeron	NULL
L	NULL
,	NULL
Li	NULL
H	NULL
,	NULL
Miura	NULL
M	NULL
,	NULL
Rotello	NULL
RJ	NULL
,	NULL
Miller	NULL
DK	NULL
,	NULL
Li	NULL
P	NULL
,	NULL
Seshadri	NULL
T	NULL
,	NULL
Yuan	NULL
J	NULL
and	NULL
Greenberg	NULL
AH	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
93	NULL
,	NULL
11002-11007	NULL
.	NULL

Shi	NULL
L	NULL
,	NULL
Kraut	NULL
RP	NULL
,	NULL
Aebersold	NULL
R	NULL
and	NULL
Greenberg	NULL
AH	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
,	NULL
553-566	NULL
.	NULL

Shi	NULL
L	NULL
,	NULL
Mai	NULL
S	NULL
,	NULL
Israels	NULL
S	NULL
,	NULL
Browne	NULL
K	NULL
,	NULL
Trapani	NULL
JA	NULL
and	NULL
Greenberg	NULL
AH	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
185	NULL
,	NULL
855-866	NULL
.	NULL

Shi	NULL
L	NULL
,	NULL
Nishioka	NULL
WK	NULL
,	NULL
Th'ng	NULL
J	NULL
,	NULL
Bradbury	NULL
EM	NULL
,	NULL
Litchfield	NULL
DW	NULL
and	NULL
Greenberg	NULL
AH	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Science	NULL
,	NULL
263	NULL
,	NULL
1143-1145	NULL
.	NULL

Stahls	NULL
AK	NULL
and	NULL
Carpen	NULL
O	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

Scand	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
29	NULL
,	NULL
211-216	NULL
.	NULL

Sutton	NULL
VR	NULL
,	NULL
Vaux	NULL
DL	NULL
and	NULL
Trapani	NULL
JA	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
158	NULL
,	NULL
5783-5790	NULL
.	NULL

Timonen	NULL
T	NULL
and	NULL
Saksela	NULL
E.	NULL
(	NULL
1980	NULL
)	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
,	NULL
36	NULL
,	NULL
285-291	NULL
.	NULL

Versteeg	NULL
R	NULL
,	NULL
Peltenburg	NULL
LT	NULL
,	NULL
Plomp	NULL
AC	NULL
and	NULL
Schrier	NULL
PI	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
143	NULL
,	NULL
4331-4337	NULL
.	NULL

Wagner	NULL
AJ	NULL
,	NULL
Kokontis	NULL
JM	NULL
and	NULL
Hay	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
2817-2830	NULL
.	NULL

Walker	NULL
TA	NULL
,	NULL
Wilson	NULL
BA	NULL
,	NULL
Lewis	NULL
AM	NULL
and	NULL
Cook	NULL
JL	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
6491-6495	NULL
.	NULL

Wright	NULL
SC	NULL
and	NULL
Bonavida	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
138	NULL
,	NULL
1791	NULL
1798	NULL
.	NULL

